-DOCSTART-	O

Multiple	O
erythematous	O
papules	O
accompanied	O
by	O
severe	O
pruritus	B-NEG
were	O
observed	O
in	O
humans	O
bitten	O
by	O
the	O
mites	O
(	O
Acari	O
)	O
Pyemotes	O
tritici	O
(	O
Newport	O
)	O
(	O
Pyemotidae	O
)	O
,	O
Dermanyssus	O
gallinae	O
(	O
De	O
Geer	O
)	O
(	O
Dermanyssidae	O
)	O
,	O
Ornithonyssus	O
bacoti	O
Hirst	O
(	O
Macronyssidae	O
)	O
and	O
Androlaelaps	O
casalis	O
(	O
Berlese	O
)	O
(	O
Laelapidae	O
)	O
.	O

-DOCSTART-	O

Four	O
geographically	O
distinct	O
colonies	O
of	O
the	O
human	O
head	B-NEG
louse	I-NEG
,	O
Pediculus	O
humanus	O
capitis	O
De	O
Geer	O
(	O
Anoplura	O
Pediculidae	O
)	O
were	O
reared	O
on	O
a	O
live	O
host	O
and	O
exhibited	O
significantly	O
different	O
life	O
history	O
patterns	O
.	O

-DOCSTART-	O

Action	O
of	O
fengsuidan	O
granules	O
on	O
experimental	O
anti-oral	B-NEG
ulcer	I-NEG
.	O

-DOCSTART-	O

We	O
investigated	O
the	O
effect	O
of	O
Maimendongtang	O
on	O
airway	O
clearance	O
and	O
secretion	B-NEG
in	O
anaesthetized	O
quails	O
.	O

-DOCSTART-	O

Furthermore	O
,	O
the	O
effects	O
of	O
Juzentaihoto	O
were	O
clearly	O
revealed	O
on	O
the	O
histological	O
findings	O
of	O
testis	B-NEG
and	O
kidney	B-NEG
.	O

-DOCSTART-	O

L	O
Yaojiu	O
was	O
investigated	O
for	O
its	O
effects	O
of	O
invigorating	O
blood	B-NEG
circulation	I-NEG
and	O
eliminating	O
blood	B-NEG
stasis	I-NEG
using	O
old	O
rats	O
(	O
aged	O
over	O
ten	O
months	O
)	O
as	O
the	O
model	O
of	O
blood	O
stasis	O
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
study	O
the	O
chemical	O
constituents	O
with	O
antiviral	O
action	O
from	O
Yinqiaosan	O
on	O
influenza	B-NEG
virus	I-NEG
.	O

-DOCSTART-	O

Effects	O
of	O
shengmaiyin	O
and	O
danshen-chuanxiong	O
decoction	O
on	O
preventing	O
cardiopulmonary	B-NEG
changes	I-NEG
in	O
adults	O
caused	O
by	O
a	O
high-altitude	O
environment	O
.	O

-DOCSTART-	O

The	O
effects	O
of	O
Guilingji	O
,	O
an	O
antiaging	O
prescription	O
comprised	O
of	O
traditional	O
Chinese	O
medicinal	O
herbs	O
and	O
animal	O
components	O
,	O
on	O
the	O
brain	B-NEG
level	O
of	O
thiobarbituric	O
acid	O
reactive	O
substances	O
(	O
TBARS	O
)	O
and	O
superoxide	O
dismutase	O
(	O
SOD	O
)	O
activity	O
in	O
the	O
brain	O
of	O
rats	O
with	O
FeCl3-induced	O
epilepsy	O
were	O
examined	O
with	O
fluorophotometry	O
and	O
electron	O
spin	O
resonance	O
(	O
ESR	O
)	O
spectrometry	O
,	O
respectively	O
.	O

-DOCSTART-	O

Suanzaorentang	O
,	O
and	O
anxiolytic	O
Chinese	O
medicine	O
,	O
affects	O
the	O
central	O
adrenergic	B-NEG
and	I-NEG
serotonergic	I-NEG
systems	I-NEG
in	O
rats	O
.	O

-DOCSTART-	O

Effects	O
of	O
tokishakuyakusan	O
and	O
keishibukuryogan	O
on	O
steroidogenesis	B-NEG
by	O
rat	O
preovulatory	O
follicles	O
in	O
vivo	O
.	O

-DOCSTART-	O

Tokishakuyakusan	O
(	O
TS	O
)	O
in	O
vivo	O
did	O
not	O
affect	O
the	O
changes	O
in	O
DNA	B-NEG
polymerase	I-NEG
alpha	I-NEG
and	I-NEG
beta	I-NEG
activities	I-NEG
during	O
the	O
estrous	O
cycle	O
.	O

-DOCSTART-	O

Debridement	O
,	O
injection	O
and	O
drug	O
covering	O
of	O
ulcer	B-NEG
surfaces	O
were	O
followed	O
by	O
oral	O
Chinese	O
medicine	O
Chuanjia	O
Weidan	O
(	O
50	O
g	O
daily	O
)	O
or	O
cimetidine	O
(	O
800	O
mg	O
every	O
night	O
)	O
for	O
4	O
weeks	O
.	O

-DOCSTART-	O

The	O
erythroid	B-NEG
colony	I-NEG
formating	I-NEG
ability	I-NEG
and	O
the	O
therapeutic	O
efficacy	O
were	O
investigated	O
in	O
patients	O
with	O
chronic	B-NEG
renal	I-NEG
failure	I-NEG
(	O
CRF	B-NEG
)	O
before	O
and	O
after	O
treatment	O
with	O
baoyuantang	O
.	O

-DOCSTART-	O

Isolation	O
and	O
elucidation	O
of	O
chemical	O
constituents	O
with	O
antiviral	O
action	O
from	O
yinqiaosan	O
on	O
influenza	B-NEG
virus	I-NEG
.	O

-DOCSTART-	O

Shosaikoto	O
and	O
Daisaikoto	O
elevated	O
the	O
mitogenic	O
activity	O
of	O
LPS	B-NEG
and	O
reduced	O
those	O
of	O
Con	B-NEG
A	I-NEG
.	O

-DOCSTART-	O

Saibokuto	O
suppressed	O
the	O
induction	O
of	O
IL2	B-NEG
responsiveness	I-NEG
induced	O
by	O
Dermatophagoides	O
farinae	O
(	O
Df	O
)	O
antigen	O
in	O
peripheral	O
blood	O
mononuclear	O
cells	O
from	O
patients	O
with	O
bronchial	B-NEG
asthma	I-NEG
.	O

-DOCSTART-	O

Effects	O
of	O
injectio	O
reduqing	O
on	O
plasma	B-NEG
IL-8	I-NEG
and	I-NEG
nitric	I-NEG
oxide	I-NEG
levels	I-NEG
in	O
rabbits	O
with	O
endotoxin	O
induced	O
disseminated	B-NEG
intravascular	I-NEG
coagulation	I-NEG
.	O

-DOCSTART-	O

The	O
recombinant	O
plasmid	O
pAGO	O
contains	O
the	O
Herpes	B-NEG
simplex	I-NEG
virus	I-NEG
type	I-NEG
1	I-NEG
(	I-NEG
HSV-1	I-NEG
)	I-NEG
thymidine	I-NEG
kinase	I-NEG
(	I-NEG
TK	I-NEG
)	I-NEG
gene	I-NEG
and	O
consists	O
of	O
a	O
2-kb	O
PvuII	O
fragment	O
of	O
HSV-1	O
DNA	O
inserted	O
into	O
the	O
PvuII	O
site	O
of	O
pBR322	O
.	O

-DOCSTART-	O

Study	O
on	O
the	O
immunoregulatory	O
effect	O
of	O
Baoyuantang	O
(	O
symbol	O
see	O
text	O
)	O
in	O
patients	O
with	O
chronic	B-NEG
hepatitis	I-NEG
B	I-NEG
.	O

-DOCSTART-	O

BACKGROUND	O
AND	O
PURPOSE	O
Chinese	O
herbal	O
medicine	O
,	O
Hochuekkito	O
is	O
widely	O
used	O
for	O
male	B-NEG
infertility	I-NEG
in	O
Japan	O
.	O

-DOCSTART-	O

When	O
120	O
mg	O
kg	O
day	O
of	O
Shosaikoto	O
extract	O
was	O
placed	O
in	O
the	O
diet	O
after	O
72	O
weeks	O
of	O
age	O
to	O
110	O
weeks	O
,	O
it	O
improved	O
age-induced	O
PAR	B-NEG
failure	I-NEG
in	O
both	O
the	O
two-compartment	O
avoidance	O
box	O
test	O
and	O
the	O
step-down	O
test	O
.	O

-DOCSTART-	O

To	O
examine	O
self-reported	O
quality	O
of	O
life	O
and	O
health	O
status	O
of	O
HIV	B-NEG
-infected	O
women	O
and	O
a	O
comparison	O
sample	O
of	O
HIV-uninfected	O
women	O
in	O
rural	O
Uganda	O
,	O
we	O
culturally	O
adapted	O
a	O
Lugandan	O
version	O
of	O
the	O
Medical	O
Outcomes	O
Survey-HIV	O
(	O
MOS-HIV	O
)	O
.	O

-DOCSTART-	O

Moreover	O
,	O
takushya	O
was	O
responsible	O
for	O
most	O
of	O
the	O
effect	O
of	O
choreito	O
consumption	O
on	O
reduction	O
of	O
urine	B-NEG
pH	I-NEG
,	O
and	O
approximately	O
half	O
its	O
ability	O
to	O
reduce	O
struvite	B-NEG
crystal	I-NEG
formation	I-NEG
in	O
cat	O
urine	O
.	O

-DOCSTART-	O

These	O
results	O
indicate	O
that	O
Ras	B-NEG
MEK	I-NEG
ERK	I-NEG
signaling	I-NEG
pathway	I-NEG
plays	O
a	O
role	O
in	O
neuroprotective	O
effects	O
of	O
Hwansodan	O
in	O
serum-deprived	O
PC12	B-NEG
cells	I-NEG
.	O

-DOCSTART-	O

Effects	O
of	O
choreito	O
consumption	O
on	O
urine	B-NEG
variables	O
of	O
healthy	O
cats	O
fed	O
a	O
magnesium-supplemented	O
commercial	O
diet	O
.	O

-DOCSTART-	O

METHODS	O
Eight	O
confirmed	O
HIV	B-NEG
AIDS	B-NEG
patients	O
(	O
AC1	O
,	O
ARC	O
6	O
,	O
AIDS	O
1	O
)	O
were	O
treated	O
with	O
TCM	O
recipes	O
(	O
802	O
,	O
806	O
,	O
809	O
,	O
810	O
,	O
Shengmaiyin	O
,	O
ZY-1	O
)	O
,	O
recheck	O
the	O
serum	O
antibody	O
and	O
immunological	O
function	O
and	O
intranuclear	O
HIV-DNA	O
was	O
investigated	O
with	O
PCR	O
amplifying	O
assay	O
and	O
were	O
long-term	O
followed-up	O
.	O

-DOCSTART-	O

Through	O
the	O
morphological	O
and	O
biochemical	O
analyses	O
,	O
it	O
was	O
shown	O
that	O
HiB5	O
cells	O
treated	O
with	O
H2O2	O
exhibit	O
classical	O
apoptotic	B-NEG
features	I-NEG
,	O
while	O
the	O
occurrence	O
of	O
such	O
changes	O
is	O
reduced	O
in	O
cells	O
pre-treated	O
with	O
Wuyaoshunqisan	O
prior	O
to	O
H2O2	O
exposure	O
.	O

-DOCSTART-	O

The	O
hormonal	O
response	O
to	O
HCG	B-NEG
stimulation	O
in	O
patients	O
with	O
male	B-NEG
infertility	I-NEG
before	O
and	O
after	O
treatment	O
with	O
hochuekkito	O
.	O

-DOCSTART-	O

CONCLUSION	O
Youguiyin	O
,	O
Sijunzitang	O
could	O
enhance	O
the	O
immunoregulatory	B-NEG
function	I-NEG
of	O
the	O
patients	O
with	O
deficiency	B-NEG
of	I-NEG
Spleen	I-NEG
and	I-NEG
Kidney	I-NEG
,	O
particularly	O
the	O
cellular	O
immune	O
functions	O
,	O
in	O
which	O
the	O
Sijunzitang	O
effect	O
is	O
more	O
complete	O
and	O
significant	O
,	O
while	O
Taohong	O
Siwutang	O
eliminated	O
the	O
effect	O
of	O
CIC	B-NEG
in	O
blood	O
better	O
.	O

-DOCSTART-	O

Although	O
normal	O
sperm	O
with	O
ASA	O
was	O
used	O
in	O
this	O
report	O
,	O
since	O
the	O
sperm	O
of	O
infertile	O
patients	O
are	O
said	O
to	O
be	O
more	O
fragile	O
,	O
this	O
results	O
imply	O
that	O
direct	O
protective	O
effect	O
is	O
one	O
of	O
the	O
mechanism	O
of	O
Hochuekkito	O
for	O
male	B-NEG
infertility	I-NEG
.	O

-DOCSTART-	O

The	O
oral	O
administration	O
of	O
7	O
.	O

5	O
g	O
day	O
of	O
Goshajinkigan	O
for	O
3	O
months	O
(	O
treatment	O
period	O
)	O
relieved	O
subjective	O
symptoms	O
of	O
numbness	B-NEG
in	O
9	O
of	O
13	O
patients	O
.	O

-DOCSTART-	O

To	O
study	O
whether	O
Saireito-stimulated	O
secretion	O
and	O
synthesis	O
of	O
ACTH	B-NEG
are	O
mediated	O
by	O
hypothalamic	O
corticotropin-releasing	O
factor	O
(	O
CRF	B-NEG
)	O
,	O
we	O
examined	O
the	O
effect	O
of	O
passive	O
immunization	O
of	O
endogenous	O
CRF	O
by	O
i	O
.	O

v	O
.	O
administration	O
of	O
CRF	O
antiserum	O
on	O
Saireito-increased	O
plasma	O
ACTH	B-NEG
levels	O
and	O
proopiomelanocortin	B-NEG
gene	I-NEG
expression	I-NEG
in	O
the	O
rat	O
anterior	O
pituitary	O
,	O
under	O
pentobarbital	O
anesthesia	O
.	O

-DOCSTART-	O

The	O
results	O
suggest	O
Foshousan	O
plus	O
Danshen	O
can	O
protect	O
erythrocytes	O
against	O
lipid	B-NEG
peroxidation	I-NEG
damage	I-NEG
,	O
thus	O
conserving	O
the	O
normal	O
form	O
,	O
structure	O
and	O
function	O
of	O
erythrocytes	O
,	O
improving	O
the	O
uteroplacental	B-NEG
blood	I-NEG
flow	I-NEG
and	O
thereby	O
increasing	O
the	O
fetal	O
mean	O
birth	B-NEG
weight	I-NEG
.	O

-DOCSTART-	O

These	O
results	O
suggest	O
that	O
Hachimijiogan	O
acts	O
on	O
the	O
afferent	B-NEG
pathway	I-NEG
from	O
the	O
urinary	O
bladder	B-NEG
to	O
the	O
locus	O
coeruleus	O
,	O
thereby	O
inhibiting	O
the	O
micturition	B-NEG
reflex	O
,	O
while	O
it	O
has	O
no	O
effects	O
on	O
the	O
efferent	B-NEG
pathway	I-NEG
from	O
the	O
locus	O
coeruleus	O
to	O
the	O
urinary	O
bladder	O
.	O

-DOCSTART-	O

Saireito	O
(	O
a	O
Chinese	O
herbal	O
drug	O
)	O
decreases	O
inhibitory	O
effect	O
of	O
prednisolone	O
and	O
accelerates	O
the	O
recovery	O
of	O
rat	O
hypothalamic-pituitary-adrenal	B-NEG
axis	I-NEG
.	O

-DOCSTART-	O

When	O
the	O
liver	B-NEG
treated	O
with	O
Daisaikoto	O
was	O
perfused	O
,	O
the	O
effect	O
of	O
dietary	O
cholesterol	B-NEG
on	O
the	O
production	O
of	O
lipoprotein	O
and	O
apolipoprotein	O
was	O
markedly	O
diminished	O
.	O

-DOCSTART-	O

Effects	O
of	O
Yunqitang	O
on	O
both	O
esophageal	B-NEG
mucosal	I-NEG
morphology	I-NEG
and	O
esophageal	B-NEG
motility	I-NEG
in	O
reflux	B-NEG
esophagitis	I-NEG
patients	O
.	O

-DOCSTART-	O

The	O
structure	O
of	O
the	O
integrated	O
DNA	B-NEG
was	O
investigated	O
proving	O
the	O
occurrence	O
of	O
a	O
duplication	O
process	O
that	O
affected	O
preferentially	O
the	O
pBR322	O
part	O
of	O
the	O
pAGO	O
DNA	O
(	O
60	O
copies	O
per	O
cell	O
)	O
.	O

-DOCSTART-	O

The	O
history	O
of	O
the	O
present	O
illness	O
indicated	O
that	O
for	O
past	O
two	O
years	O
,	O
she	O
had	O
been	O
taking	O
a	O
Chinese	O
herbal	O
medicine	O
(	O
Shosaikoto	O
)	O
,	O
believed	O
to	O
be	O
used	O
for	O
the	O
treatment	O
of	O
liver	B-NEG
dysfunction	I-NEG
of	O
unknown	O
etiology	O
.	O

-DOCSTART-	O

Treatment	O
of	O
C6-glial	B-NEG
cells	I-NEG
with	O
LPS	B-NEG
PMA	B-NEG
induced	O
the	O
transcriptional	B-NEG
activation	I-NEG
of	I-NEG
NF-kappaB	I-NEG
,	O
which	O
was	O
markedly	O
inhibited	O
by	O
Samultang	O
.	O

-DOCSTART-	O

Prevalence	O
and	O
levels	O
of	O
permethrin	B-NEG
resistance	I-NEG
in	O
Pediculus	O
humanus	O
capitis	O
De	O
Geer	O
(	O
Anoplura	O
Pediculidae	O
)	O
from	O
Buenos	O
Aires	O
,	O
Argentina	O
.	O

-DOCSTART-	O

RESULTS	O
The	O
Reduqing	O
eye	O
drop	O
at	O
maximal	O
non-toxic	O
concentration	O
could	O
obviously	O
inhibit	O
the	O
cytopatic	B-NEG
effect	I-NEG
induced	O
by	O
100TCID50	O
and	O
10TCID50	O
HSV-I	O
.	O

-DOCSTART-	O

We	O
referred	O
to	O
SIGO	O
1999	O
guidelines	O
for	O
CIN	O
therapy	O
and	O
to	O
European	O
guidelines	O
for	O
cervical	O
condylomata	B-NEG
therapy	O
.	O

-DOCSTART-	O

We	O
treated	O
53	O
patients	O
for	O
male	B-NEG
infertility	I-NEG
with	O
TSUMURA	O
-	O
Hachimijiogan	O
given	O
as	O
a	O
daily	O
dose	O
of	O
7	O
.	O

5	O
g	O
for	O
144	O
days	O
on	O
the	O
average	O
.	O

-DOCSTART-	O

However	O
,	O
there	O
were	O
no	O
significant	O
changes	O
in	O
the	O
arteriolar	B-NEG
diameter	I-NEG
and	O
the	O
heart	B-NEG
rate	I-NEG
in	O
all	O
groups	O
treated	O
with	O
or	O
without	O
Sinitang	O
.	O

-DOCSTART-	O

AIM	O
To	O
investigate	O
the	O
role	O
of	O
tumor	B-NEG
necrosis	I-NEG
factor	I-NEG
(	O
TNF	O
)	O
in	O
lung	B-NEG
injury	I-NEG
during	O
acute	B-NEG
necrotizing	I-NEG
pancreatitis	I-NEG
(	O
ANP	O
)	O
,	O
and	O
the	O
therapeutic	O
effect	O
of	O
Tong	O
Xia	O
purgative	O
method	O
in	O
minimizing	O
the	O
severity	O
of	O
lung	O
injury	O
.	O

METHODS	O
Fourteen	O
canines	O
were	O
randomly	O
divided	O
into	O
3	O
groups	O
the	O
Tong	O
Xia	O
treatment	O
group	O
(	O
n	O
5	O
)	O
using	O
Dachengqitang	O
saline	O
control	O
group	O
(	O
n	O
5	O
)	O
,	O
and	O
the	O
sham	O
operation	O
group	O
(	O
n	O
4	O
)	O
.	O

-DOCSTART-	O

Kampo	O
preparations	O
for	O
prostatic	B-NEG
hyperplasia	I-NEG
usefulness	O
of	O
Saireito	O
for	O
nocturia	B-NEG
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
explore	O
the	O
anti-oral	B-NEG
ulcer	I-NEG
action	O
,	O
anti-inflammatory	B-NEG
and	I-NEG
analgesic	I-NEG
effect	I-NEG
of	O
Fengsuidan	O
Granules	O
(	O
FSDG	O
)	O
.	O

-DOCSTART-	O

In	O
accordance	O
with	O
the	O
International	O
Code	O
of	O
Zoological	O
Nomenclature	O
,	O
the	O
names	O
of	O
Pediculus	O
humanus	O
L	O
.	O
,	O
1758	O
,	O
and	O
Pediculus	B-NEG
corporis	I-NEG
De	O
Geer	O
,	O
1778	O
,	O
are	O
proposed	O
for	O
head	B-NEG
and	I-NEG
body	I-NEG
lice	I-NEG
,	O
respectively	O
.	O

-DOCSTART-	O

To	O
study	O
the	O
expression	O
of	O
SV40	B-NEG
tsA	I-NEG
genomes	I-NEG
that	O
had	O
been	O
non-selectively	O
introduced	O
into	O
mouse	O
cells	O
,	O
SV40	O
tsA207	O
DNA	O
was	O
cleaved	O
with	O
BamH	O
I	O
and	O
ligated	O
to	O
BamH	O
I-cleaved	O
plasmid	O
pAGO	O
DNA	O
,	O
which	O
contains	O
a	O
functional	O
HSV-1	B-NEG
thymidine	I-NEG
kinase	I-NEG
(	I-NEG
TK	I-NEG
)	I-NEG
gene	I-NEG
in	O
the	O
form	O
of	O
2	O
kbp	O
Pvu	O
II	O
fragment	O
inserted	O
at	O
the	O
Pvu	O
II	O
site	O
of	O
pBR322	O
.	O

-DOCSTART-	O

We	O
have	O
generated	O
L-selectin-deficient	O
mice	O
by	O
targeted	O
disruption	O
,	O
and	O
have	O
confirmed	O
a	O
previously	O
reported	O
phenotype	O
which	O
includes	O
strikingly	O
impaired	O
contact	B-NEG
hypersensitivity	I-NEG
(	O
CHS	B-NEG
)	O
responses	O
to	O
reactive	O
haptens	O
(	O
Tedder	O
,	O
T	O
.	O
F	O
.	O
,	O
D	O
.	O
A	O
.	O
Steeber	O
,	O
and	O
P	O
.	O
Pizcueta	O
.	O
1995	O
.	O
J	O
.	O
Exp	O
.	O
Med	O
.	O
181	O
2259-2264	O
Xu	O
,	O
J	O
.	O
C	O
.	O
,	O
I	O
.	O
S	O
.	O
Grewal	O
,	O
G	O
.	O
P	O
.	O
Geba	O
,	O
and	O
R	O
.	O
A	O
.	O
Flavell	O
.	O
1996	O
.	O
183	O
589-598	O
.	O
)	O
.	O

-DOCSTART-	O

These	O
Shosaikoto	O
effects	O
may	O
prevent	O
foam	B-NEG
cell	I-NEG
formation	I-NEG
and	O
the	O
progression	O
of	O
atherosclerotic	B-NEG
lesions	I-NEG
.	O

-DOCSTART-	O

OBJECT	O
To	O
perform	O
experimental	O
pharmacodynamic	B-NEG
evaluation	O
of	O
a	O
new	O
TCM	O
antidiabetic	O
drug	O
Yitangyin	O
(	O
YTY	O
)	O
.	O

-DOCSTART-	O

All	O
the	O
three	O
extracts	O
from	O
Gaoyao	O
and	O
Wuchuan	O
could	O
inhibit	O
the	O
ACh	B-NEG
-as	O
well	O
as	O
BaCl2-induced	B-NEG
spasmodic	I-NEG
and	O
automatic	B-NEG
contraction	I-NEG
of	O
isolated	O
rabbit	O
intestine	O
.	O

-DOCSTART-	O

Shosaikoto	O
has	O
been	O
identified	O
as	O
the	O
cause	O
of	O
interstitial	B-NEG
pneumonia	I-NEG
or	O
eosinophilic	B-NEG
pneumonia	I-NEG
,	O
but	O
pulmonary	B-NEG
edema	I-NEG
associated	O
with	O
Shosaikoto	O
has	O
not	O
been	O
previously	O
described	O
.	O

-DOCSTART-	O

The	O
mitogenic	O
activities	O
of	O
PMA	B-NEG
and	O
PHA	B-NEG
were	O
elevated	O
by	O
low	O
doses	O
of	O
Shosaikoto	O
and	O
Daisaikoto	O
and	O
suppressed	O
by	O
high	O
doses	O
.	O

-DOCSTART-	O

Jagamchotang	O
has	O
been	O
used	O
for	O
treatment	O
of	O
ischemic	B-NEG
myocardial	I-NEG
diseases	I-NEG
in	O
Chinese	O
traditional	O
medicine	O
.	O

-DOCSTART-	O

For	O
a	O
while	O
,	O
the	O
water	O
extract	O
of	O
Jagamchotang	O
stimulates	O
myocardial	B-NEG
cells	I-NEG
in	I-NEG
ischemic	I-NEG
condition	O
to	O
produce	O
nitric	B-NEG
oxide	I-NEG
(	O
NO	B-NEG
)	O
in	O
a	O
dose	O
dependent	O
manner	O
and	O
it	O
protects	O
the	O
damage	B-NEG
of	I-NEG
myocardial	I-NEG
cells	I-NEG
.	O

-DOCSTART-	O

1	O
)	O
Saireito	O
caused	O
a	O
significant	O
increase	O
of	O
daytime	O
urine	B-NEG
output	I-NEG
and	O
significantly	O
reduced	O
nocturnal	O
output	O
.	O

-DOCSTART-	O

From	O
the	O
above	O
findings	O
Seishinrenshiin	O
was	O
expected	O
to	O
be	O
both	O
effective	O
for	O
the	O
patients	O
who	O
have	O
constitutionally	O
infirm	O
stomach	B-NEG
and	O
intestines	B-NEG
and	O
can	O
be	O
used	O
safely	O
.	O

-DOCSTART-	O

The	O
effect	O
of	O
maimendongtang	O
on	O
airway	B-NEG
clearance	O
and	O
secretion	B-NEG
.	O

-DOCSTART-	O

As	O
a	O
result	O
,	O
in	O
the	O
case	O
of	O
rats	O
with	O
carrageenin	O
cotton	O
pellet-induced	O
granuloma	O
,	O
a	O
significant	O
inhibitory	O
effect	O
on	O
granuloma	B-NEG
formation	I-NEG
was	O
observed	O
in	O
the	O
Orengedokuto	O
treated	O
rats	O
(	O
150	O
mg	O
kg	O
day	O
)	O
which	O
showed	O
a	O
decrease	O
in	O
serum	O
lipid	O
peroxide	O
(	O
p	O
0	O
.	O
001	O
)	O
and	O
an	O
increase	O
in	O
acid	O
soluble	O
glycoprotein	O
(	O
p	O
0	O
.	O
001	O
)	O
.	O

-DOCSTART-	O

Goshajinkigan	O
(	O
niu-che-shen-qi-wan	O
in	O
Chinese	O
)	O
,	O
a	O
traditional	O
herbal	O
medicine	O
,	O
has	O
been	O
used	O
in	O
Japan	O
to	O
treat	O
clinical	O
symptoms	O
of	O
diabetic	B-NEG
neuropathy	I-NEG
.	O

-DOCSTART-	O

This	O
study	O
was	O
designed	O
to	O
evaluate	O
whether	O
the	O
water	O
extract	O
of	O
Samultang	O
may	O
modulate	O
the	O
production	B-NEG
of	I-NEG
nitric	I-NEG
oxide	I-NEG
(	O
NO	O
)	O
in	O
LPS	O
and	O
PMA	O
treated-C6	O
glial	O
cells	O
to	O
protect	O
the	O
cells	O
from	O
NO	B-NEG
-induced	O
cytotoxicity	B-NEG
.	O

-DOCSTART-	O

These	O
results	O
suggest	O
that	O
tokishakuyakusan	O
improves	O
luteal	B-NEG
insufficiency	I-NEG
in	O
women	O
but	O
does	O
not	O
affect	O
the	O
hormonal	O
levels	O
of	O
women	O
with	O
normal	O
menstrual	O
cycles	O
.	O

-DOCSTART-	O

Seven	O
days	O
after	O
hCG	B-NEG
treatment	O
,	O
the	O
resected	O
ovaries	O
were	O
incubated	O
in	O
vitro	O
with	O
herbal	O
components	O
of	O
Tokishakuyakusan	O
(	O
TS	O
)	O
.	O

-DOCSTART-	O

This	O
paper	O
has	O
shown	O
that	O
the	O
pathologic	O
damages	B-NEG
done	O
to	O
rat	O
s	O
viscera	B-NEG
due	O
to	O
hypoxic	B-NEG
environment	O
of	O
altitude	O
can	O
be	O
reduced	O
significantly	O
by	O
oral	O
administrations	O
of	O
Shengmaiyin	O
,	O
Danshen-Chuanxiong	O
mixture	O
and	O
Rhodiola	O
kirilowii	O
.	O

-DOCSTART-	O

Saireito	O
decreased	O
the	O
hypothalamic	O
CRF	B-NEG
level	O
due	O
to	O
an	O
early	O
release	O
of	O
CRF	O
and	O
stimulated	O
ACTH	B-NEG
release	O
and	O
POMC	B-NEG
gene	I-NEG
expression	I-NEG
but	O
did	O
not	O
increase	O
CRF	B-NEG
gene	I-NEG
expression	I-NEG
.	O

-DOCSTART-	O

Four	O
psychometric	O
scales	O
Corah	O
Dental	O
Anxiety	O
Scale	O
(	O
CDAS	O
)	O
,	O
a	O
modified	O
version	O
of	O
the	O
Geer	O
Fear	O
Scale	O
(	O
GFS	O
)	O
,	O
the	O
Health	O
Locus	O
of	O
Control	O
Scale	O
(	O
HLCS	O
)	O
,	O
and	O
a	O
Mood	O
Adjective	O
Check	O
List	O
(	O
MACL	O
)	O
,	O
were	O
studied	O
with	O
regard	O
to	O
their	O
implications	O
for	O
dental	B-NEG
fear	I-NEG
.	O

-DOCSTART-	O

These	O
observations	O
confirm	O
that	O
Goshajinkigan	O
relieves	O
subjective	O
symptoms	O
and	O
demonstrate	O
that	O
it	O
improves	O
vibration	B-NEG
sensation	O
in	O
patients	O
with	O
diabetic	O
neuropathy	O
.	O

-DOCSTART-	O

The	O
older	O
ganglion	B-NEG
cells	O
also	O
express	O
a	O
slowly	O
activating	O
K	O
(	O
)	O
current	O
(	O
IKsa	O
)	O
.	O

-DOCSTART-	O

Since	O
this	O
theoryis	O
not	O
found	O
in	O
medical	O
books	O
before	O
the	O
Tang	O
era	O
,	O
and	O
since	O
many	O
examples	O
can	O
be	O
found	O
in	O
the	O
Heji	O
Jufang	O
and	O
other	O
medical	O
books	O
of	O
the	O
same	O
period	O
,	O
we	O
believe	O
this	O
is	O
a	O
view	O
of	O
pathology	O
peculiar	O
to	O
the	O
Northern	O
Sung	O
era	O
.	O
(	O
2	O
)	O
A	O
comparison	O
of	O
the	O
components	O
of	O
prescriptions	O
used	O
in	O
the	O
Waitai	O
Miyaofang	O
and	O
the	O
tanyin	O
chapter	O
of	O
the	O
Heji	O
Jufang	O
revealed	O
that	O
the	O
former	O
contains	O
many	O
strong	O
diuretics	O
,	O
purgatives	O
,	O
and	O
crude	O
drugs	O
of	O
a	O
hot	O
nature	O
,	O
while	O
the	O
later	O
contains	O
few	O
of	O
these	O
but	O
many	O
diuretics	O
that	O
have	O
a	O
mild	O
antitussive	B-NEG
effect	I-NEG
.	O

-DOCSTART-	O

Protective	O
effect	O
of	O
reduqing	O
injection	O
on	O
rabbits	O
with	O
acute	B-NEG
lung	I-NEG
injury	I-NEG
.	O

-DOCSTART-	O

Head	B-NEG
lice	I-NEG
are	O
caused	O
by	O
the	O
host-specific	O
,	O
ectoparasitic	O
insect	O
Pediculus	O
humanus	O
capitis	O
De	O
Geer	O
and	O
remain	O
a	O
common	O
human	O
infestation	O
.	O

-DOCSTART-	O

The	O
Reduqing	O
eye	O
drop	O
showed	O
remarkably	O
low	O
toxic	B-NEG
effect	I-NEG
to	O
the	O
cells	O
as	O
compared	O
to	O
acyclovir	O
eye	O
drop	O
.	O

-DOCSTART-	O

The	O
effect	O
of	O
Tokishakuyakusan	O
(	O
TS	O
)	O
or	O
Keishibukuryogan	O
(	O
KB	O
)	O
on	O
endothelin-1	B-NEG
(	O
ET-1	O
)	O
,	O
a	O
newly	O
identified	O
peptide	O
,	O
in	O
plasma	O
and	O
amniotic	O
fluid	O
from	O
TS-	O
or	O
KB-treated	O
women	O
or	O
normal	O
pregnant	O
women	O
following	O
TS	O
or	O
KB	O
treatment	O
was	O
studied	O
during	O
the	O
menstrual	O
cycle	O
,	O
gestation	O
,	O
delivery	O
and	O
the	O
post-partum	O
period	O
.	O

-DOCSTART-	O

On	O
the	O
other	O
hand	O
,	O
Daiobotanpito	O
and	O
Tokakujokito	O
were	O
not	O
blocked	O
by	O
treatment	O
with	O
those	O
four	O
inhibitors	B-NEG
.	O

-DOCSTART-	O

Hachimijiogan	O
(	O
H	O
)	O
,	O
its	O
components	O
and	O
Ninjin	O
(	O
N	O
)	O
were	O
administered	O
orally	O
to	O
the	O
animals	O
for	O
28	O
days	O
,	O
and	O
the	O
weight	B-NEG
of	O
the	O
various	O
organs	O
,	O
pituitary	O
content	O
of	O
FSH	O
,	O
LH	O
and	O
PRL	O
,	O
and	O
serum	O
concentration	O
of	O
FSH	B-NEG
,	O
LH	B-NEG
,	O
PRL	B-NEG
and	O
testosterone	B-NEG
were	O
measured	O
.	O

-DOCSTART-	O

An	O
illustration	O
of	O
the	O
feasibility	O
of	O
extending	O
the	O
dose	O
reconstruction	O
is	O
provided	O
by	O
a	O
sample	O
calculation	O
to	O
estimate	O
radiation	B-NEG
exposures	I-NEG
to	O
the	O
thyroid	B-NEG
from	O
eating	O
radio-iodine-contaminated	O
rabbit	O
thyroids	O
after	O
the	O
Sedan	O
test	O
.	O

-DOCSTART-	O

In	O
addition	O
,	O
proteolysis	O
of	O
this	O
region	O
has	O
been	O
observed	O
previously	O
in	O
a	O
bc	O
(	O
1	O
)	O
complex	O
mutant	B-NEG
of	O
R	O
.	O
capsulatus	O
Saribas	O
,	O
A	O
.	O

S	O
.	O
,	O
Valkova-Valchanova	O
,	O
M	O
.	O

B	O
.	O
,	O
Tokito	O
,	O
M	O
.	O
,	O
Zhang	O
,	O
Z	O
.	O
,	O
Berry	O
E	O
.	O

A	O
.	O
,	O
and	O
Daldal	O
,	O
F	O
.	O
(	O
1998	O
)	O
Biochemistry	O
37	O
,	O
8105-8114	O
.	O

-DOCSTART-	O

CONCLUSION	O
Didang	O
Tang	O
and	O
Guizhifuling	O
pills	O
can	O
reduce	O
the	O
expressions	O
of	O
hTERT	B-NEG
,	O
p53	B-NEG
,	O
c-	B-NEG
erbB-2	I-NEG
and	O
Bcl-2	B-NEG
,	O
while	O
Danshenyin	O
can	O
only	O
reduce	O
the	O
expression	O
of	O
hTERT	B-NEG
without	O
similar	O
effects	O
on	O
the	O
other	O
3	O
oncogenes	O
.	O

-DOCSTART-	O

The	O
above	O
anti-glucocorticoids	O
and	O
the	O
m-RNA	O
and	O
protein	O
synthesis	O
inhibitors	O
suppressed	O
the	O
anti-inflammatory	B-NEG
effects	I-NEG
of	O
Daisaikoto	O
and	O
Shosaikoto	O
dose-dependently	O
.	O

-DOCSTART-	O

Effects	O
of	O
kamikihito	O
,	O
a	O
traditional	O
Chinese	O
medicine	O
,	O
on	O
neurotransmitter	B-NEG
receptor	I-NEG
binding	I-NEG
in	O
the	O
aged	O
rat	O
brain	O
determined	O
by	O
in	O
vitro	O
autoradiography	O
(	O
1	O
)	O
Changes	O
in	O
the	O
3H	B-NEG
QNB	I-NEG
binding	I-NEG
.	O

-DOCSTART-	O

Subjects	O
were	O
208	O
persons	O
with	O
dental	B-NEG
fear	I-NEG
who	O
were	O
telephone	O
interviewed	O
,	O
of	O
whom	O
a	O
subsample	O
of	O
155	O
responded	O
to	O
a	O
mailed	O
Dental	O
Anxiety	O
Scale	O
(	O
DAS	O
)	O
,	O
State-Trait	O
Anxiety	O
Inventory	O
and	O
a	O
modified	O
FSS-II	O
Geer	O
Fear	O
Scale	O
(	O
GFS	O
)	O
.	O

-DOCSTART-	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
5-hydroxytryptophan	O
(	O
5-HTP	O
)	O
induced	O
decrease	O
in	O
locomotor	O
activity	O
was	O
significantly	O
antagonized	O
by	O
Suanzaorentang	O
,	O
p-chlorophenylalanine	B-NEG
(	O
p-CPA	O
)	O
induced	O
increase	O
in	O
locomotor	O
activity	O
was	O
significantly	O
inhibited	O
by	O
Suanzaorentang	O
,	O
Suanzaorentang	O
had	O
no	O
significant	O
effects	O
on	O
baclofen	O
,	O
muscimol	B-NEG
,	O
aminooxyacetic	B-NEG
acid	I-NEG
(	O
AOAA	O
)	O
and	O
thiosemicarbazide	O
induced	O
changes	O
in	O
locomotor	O
activity	O
,	O
Suanzaorentang	O
significantly	O
decreased	O
vanillylmandelic	B-NEG
acid	I-NEG
(	O
VMA	B-NEG
)	O
in	O
striatum	O
and	O
hippocampus	O
,	O
homovanillic	B-NEG
acid	I-NEG
(	O
HVA	B-NEG
)	O
in	O
hippocampus	O
and	O
5-hydroxyindol	B-NEG
acetic	I-NEG
acid	I-NEG
(	O
5-HIAA	B-NEG
)	O
in	O
striatum	O
and	O
hypothalamus	O
,	O
Suanzaorentang	O
significantly	O
reversed	O
the	O
alpha-methyltyrosine	O
(	O
alpha-MT	O
)	O
produced	O
decrease	O
in	O
DA	B-NEG
concentrations	O
in	O
striatum	O
and	O
hippocampus	O
,	O
and	O
(	O
6	O
)	O
Suanzaorentang	O
significantly	O
reversed	O
the	O
p-CPA	O
produced	O
decrease	O
in	O
5-HT	B-NEG
concentrations	O
on	O
amygdala	O
.	O

-DOCSTART-	O

Tsumura	O
Hachimijiogan	O
,	O
7	O
.	O

5	O
g	O
a	O
day	O
,	O
was	O
administered	O
to	O
30	O
patients	O
with	O
benign	B-NEG
prostatic	I-NEG
hypertrophy	I-NEG
(	O
BPH	B-NEG
)	O
.	O

-DOCSTART-	O

Effects	O
of	O
goshajinkigan	O
on	O
corneal	B-NEG
sensitivity	I-NEG
,	O
superficial	B-NEG
punctate	I-NEG
keratopathy	I-NEG
and	O
tear	B-NEG
secretion	O
in	O
patients	O
with	O
insulin-dependent	B-NEG
diabetes	I-NEG
mellitus	I-NEG
.	O

-DOCSTART-	O

The	O
results	O
showed	O
that	O
the	O
concentrations	B-NEG
of	I-NEG
zinc	I-NEG
and	I-NEG
calcium	I-NEG
in	O
wheat	O
and	O
maize	O
from	O
Linzhou	O
were	O
significantly	O
lower	O
than	O
these	O
from	O
Yuzhou	O
,	O
the	O
copper	O
concentrations	O
in	O
grains	O
were	O
higher	O
and	O
the	O
iron	O
in	O
maize	O
was	O
lower	O
.	O

-DOCSTART-	O

These	O
result	O
indicate	O
that	O
Shosaikoto	O
facilitates	O
oxidized	O
LDL	O
catabolism	B-NEG
in	O
macrophages	O
,	O
resulting	O
in	O
the	O
augmentation	O
of	O
oxidized	B-NEG
LDL	I-NEG
uptake	I-NEG
and	O
the	O
elimination	O
of	O
cholesterol	B-NEG
from	O
macrophages	O
by	O
HDL	O
.	O

-DOCSTART-	O

The	O
results	O
showed	O
that	O
pretreatment	O
of	O
rats	O
with	O
Guilingji	O
decreased	O
the	O
levels	O
of	O
TBARS	B-NEG
in	O
the	O
left	O
cortex	O
,	O
midbrain	O
,	O
and	O
olfactory	O
lobe	O
,	O
and	O
increased	O
the	O
SOD	B-NEG
activity	I-NEG
in	O
the	O
midbrain	O
and	O
hypothalamus	O
.	O

-DOCSTART-	O

Restorative	O
effect	O
of	O
shosaikoto	O
(	O
kampo	O
medicine	O
)	O
on	O
diminution	O
of	O
nitric	B-NEG
oxide	I-NEG
synthesis	I-NEG
in	O
murine	O
peritoneal	O
macrophages	O
induced	O
by	O
hypercholesterolemia	B-NEG
.	O

-DOCSTART-	O

The	O
effect	O
of	O
Shengmaisan	O
(	O
SMS	O
)	O
on	O
62	O
acute	O
viral	B-NEG
myocarditis	I-NEG
patients	O
and	O
its	O
peroxidation	B-NEG
damage	I-NEG
was	O
studied	O
.	O

-DOCSTART-	O

Pulmonary	B-NEG
edema	I-NEG
associated	O
with	O
the	O
Chinese	O
medicine	O
shosaikoto	O
.	O

-DOCSTART-	O

The	O
results	O
showed	O
antibacterial	B-NEG
activity	I-NEG
of	O
Bazhengsan	O
was	O
the	O
highest	O
,	O
with	O
a	O
MIC	O
from	O
6	O
.	O

25	O
mg	O
ml	O
to	O
25	O
mg	O
ml	O
.	O
when	O
the	O
concentration	O
of	O
Bazhengsan	O
was	O
100	O
mg	O
ml	O
or	O
over	O
,	O
all	O
the	O
Diplocous	O
gonorrhoeae	B-NEG
tested	O
would	O
be	O
killed	O
within	O
ten	O
minutes	O
.	O

-DOCSTART-	O

Results	O
showed	O
that	O
Scutellaria	O
barbata	O
,	O
Hedyotis	O
diffusa	O
wildi	O
,	O
Xihuangwan	O
,	O
green	O
tea	O
and	O
tea	O
polyphenol	O
all	O
had	O
anti-mutagenic	B-NEG
effects	I-NEG
,	O
to	O
some	O
extent	O
.	O

-DOCSTART-	O

Identification	O
of	O
two	O
allatostatins	O
from	O
the	O
cricket	O
,	O
Gryllus	O
bimaculatus	O
de	O
Geer	O
(	O
Ensifera	O
,	O
Gryllidae	O
)	O
additional	O
members	O
of	O
a	O
family	O
of	O
neuropeptides	O
inhibiting	O
juvenile	O
hormone	B-NEG
biosynthesis	I-NEG
.	O

-DOCSTART-	O

Effect	O
of	O
zuoguiwan	O
on	O
early	B-NEG
embryonic	I-NEG
development	I-NEG
of	O
mice	O
.	O

-DOCSTART-	O

The	O
effect	O
of	O
a	O
dietary	O
supplement	O
,	O
choreito	O
,	O
on	O
in	O
vitro	O
struvite	B-NEG
crystal	I-NEG
growth	O
in	O
feline	O
urine	O
was	O
evaluated	O
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
investigate	O
the	O
therapeutic	O
efficacy	O
of	O
traditional	O
Chinese	O
medicine	O
Reduqing	O
(	O
RDQ	O
)	O
against	O
human	O
cytomegalovirus	B-NEG
(	O
HCMV	O
)	O
in	O
clinical	O
and	O
its	O
antiviral	B-NEG
activity	I-NEG
in	O
vitro	O
.	O

-DOCSTART-	O

Efficacy	O
of	O
Shiunko	O
for	O
the	O
treatment	O
of	O
atopic	B-NEG
dermatitis	I-NEG
.	O

-DOCSTART-	O

Hachimijiogan	O
(	O
0	O
.	O
5	O
and	O
1	O
.	O
0	O
g	O
kg	O
,	O
p	O
.	O
o	O
.	O
)	O
also	O
ameliorated	O
the	O
cerebral	O
ischemia	B-NEG
-induced	O
amnesia	B-NEG
.	O

-DOCSTART-	O

AIM	O
To	O
observe	O
the	O
therapeutic	O
effects	O
of	O
Sishengtang	O
decoction	O
in	O
alleviating	O
the	O
toxic	B-NEG
and	O
side	O
effects	O
of	O
transarterial	O
embolization	O
(	O
TAE	O
)	O
.	O

-DOCSTART-	O

Zixuedan	O
,	O
a	O
traditional	O
Chinese	O
remedy	O
for	O
dissipation	O
of	O
pathogenic	O
heat	B-NEG
and	O
detoxification	B-NEG
that	O
could	O
reduce	O
WBC	O
count	O
including	O
leukemic	O
cells	O
below	O
1000	O
microliters	O
without	O
intolerable	O
side	O
effects	O
,	O
was	O
prescribed	O
for	O
treatment	O
.	O

-DOCSTART-	O

In	O
the	O
present	O
study	O
,	O
we	O
examined	O
the	O
effect	O
of	O
food	O
containing	O
saireito	O
(	O
1	O
.	O
5	O
)	O
on	O
the	O
recovery	O
of	O
the	O
hypothalamic-pituitary-adrenal	B-NEG
axis	I-NEG
after	O
treating	O
male	O
rats	O
with	O
prednisolone	O
(	O
PSL	O
,	O
200	O
microM	O
)	O
in	O
drinking	O
water	O
for	O
14	O
days	O
.	O

-DOCSTART-	O

Effects	O
of	O
combined	O
use	O
of	O
Shosaikoto	O
(	O
one	O
of	O
the	O
famous	O
crude	O
Chinese	O
medicines	O
)	O
and	O
prednisolone	O
were	O
examined	O
in	O
anti-inflammatory	B-NEG
effects	I-NEG
,	O
using	O
the	O
carrageenan	O
edema	O
and	O
the	O
cotton	O
pellet	O
methods	O
.	O

-DOCSTART-	O

Pingandan	O
was	O
a	O
secret	O
prescription	O
for	O
treatment	O
of	O
stomach	B-NEG
upset	I-NEG
,	O
nausea	B-NEG
and	O
vomiting	B-NEG
for	O
emperors	O
in	O
the	O
Qing	O
Dynasty	O
of	O
China	O
.	O

-DOCSTART-	O

Samultang	O
has	O
been	O
traditionally	O
used	O
for	O
treatment	O
of	O
ischemic	B-NEG
heart	I-NEG
and	O
brain	B-NEG
diseases	I-NEG
in	O
oriental	O
medicine	O
.	O

-DOCSTART-	O

On	O
murine	O
bladder	B-NEG
tumor	I-NEG
,	O
when	O
the	O
mice	O
were	O
treated	O
with	O
the	O
mixture	O
diet	O
of	O
1	O
or	O
0	O
.	O

5	O
Juzentaihoto	O
and	O
injected	O
CDDP	O
(	O
2	O
.	O
5	O
mg	O
kg	O
week	O
)	O
for	O
8	O
weeks	O
,	O
significantly	O
greater	O
inhibition	O
of	O
the	O
tumor	B-NEG
growth	I-NEG
and	O
prolongation	O
of	O
the	O
survival	O
rate	O
were	O
observed	O
than	O
those	O
in	O
the	O
group	O
of	O
CDDP	O
alone	O
.	O

-DOCSTART-	O

METHODS	O
Wistar	O
rats	O
were	O
divided	O
into	O
wet-heat	B-NEG
syndrome	I-NEG
group	O
,	O
qingxiangsan	O
group	O
and	O
normal	O
control	O
group	O
.	O

-DOCSTART-	O

Effects	O
of	O
herbal	O
components	O
of	O
tokishakuyakusan	O
on	O
progesterone	B-NEG
secretion	O
by	O
corpus	O
luteum	O
in	O
vitro	O
.	O

-DOCSTART-	O

The	O
results	O
suggest	O
that	O
Shiunko	O
is	O
an	O
effective	O
ointment	O
for	O
cutaneous	B-NEG
injuries	I-NEG
.	O

-DOCSTART-	O

Studies	O
in	O
non-T	O
cells	O
have	O
demonstrated	O
regulation	O
of	O
the	O
tyrosine	O
focal	O
adhesion	O
kinase	O
pp125FAK	B-NEG
by	O
beta	O
1	O
integrin	O
engagement	O
and	O
,	O
most	O
recently	O
,	O
indicate	O
a	O
role	O
for	O
pp125FAK	O
in	O
linking	O
integrin-mediated	O
signal	O
transduction	O
to	O
the	O
Ras	O
pathway	O
(	O
Schaller	O
,	O
M	O
.	O
D	O
.	O
,	O
and	O
J	O
.	O
T	O
.	O
Parsons	O
,	O
1994	O
,	O
Curr	O
.	O
Opin	O
.	O
Cell	O
.	O
Biol	O
.	O
6	O
705-710	O
Schlaepfer	O
,	O
D	O
.	O
D	O
.	O
,	O
S	O
.	O
K	O
.	O
Hanks	O
,	O
T	O
.	O
Hunter	O
,	O
and	O
P	O
.	O
Van	O
der	O
Geer	O
.	O
1994	O
.	O
Nature	O
(	O
Lond	O
.	O
)	O
,	O
372	O
786-790	O
)	O
.	O

-DOCSTART-	O

Furthermore	O
,	O
the	O
effects	O
of	O
tokishakuyakusan	O
on	O
prolactin	B-NEG
,	O
gonadotropins	B-NEG
,	O
steroids	B-NEG
,	O
angiotensin	B-NEG
II	I-NEG
,	O
ANP	B-NEG
and	O
renin	B-NEG
levels	I-NEG
in	O
the	O
blood	O
of	O
women	O
with	O
normal	O
menstrual	O
cycles	O
were	O
studied	O
,	O
as	O
were	O
the	O
medicine	O
s	O
effects	O
on	O
estrogens	B-NEG
,	O
pregnenediol	O
and	O
LH	B-NEG
in	O
the	O
urine	O
of	O
the	O
same	O
women	O
.	O

-DOCSTART-	O

Effects	O
of	O
Hachimijiogan	O
on	O
hypothalamo-pituitary-testicular	B-NEG
system	I-NEG
.	O

-DOCSTART-	O

The	O
results	O
suggest	O
that	O
Shiunko	O
may	O
have	O
antibacterial	O
effects	O
on	O
staphylococci	B-NEG
,	O
and	O
may	O
be	O
an	O
effective	O
treatment	O
for	O
atopic	B-NEG
dermatitis	I-NEG
and	O
other	O
skin	B-NEG
infections	I-NEG
caused	O
mainly	O
by	O
Staphylococcus	B-NEG
species	O
.	O

-DOCSTART-	O

Also	O
,	O
Sijunzitang	O
could	O
increase	O
the	O
level	B-NEG
of	I-NEG
IL-2	I-NEG
in	O
blood	O
and	O
the	O
phagocytic	B-NEG
function	I-NEG
of	I-NEG
neutrophil	I-NEG
(	O
P	O
0	O
.	O
05	O
)	O
the	O
Taohong	O
Siwutang	O
could	O
lower	O
the	O
level	O
of	O
CIC	B-NEG
to	O
patients	O
with	O
blood	B-NEG
stasis	I-NEG
syndrome	I-NEG
(	O
P	O
0	O
.	O
01	O
)	O
,	O
increase	O
the	O
activity	B-NEG
of	I-NEG
NK	I-NEG
cells	I-NEG
(	O
P	O
0	O
.	O
05	O
)	O
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
observe	O
the	O
effects	O
of	O
Yunqitang	O
(	O
YQT	O
)	O
on	O
both	O
esophageal	B-NEG
mucosal	I-NEG
morphology	I-NEG
and	O
esophageal	B-NEG
motility	I-NEG
in	O
patients	O
with	O
reflux	B-NEG
esophagitis	I-NEG
(	O
RE	O
)	O
.	O

-DOCSTART-	O

In	O
this	O
study	O
,	O
we	O
observed	O
the	O
inhibitory	O
action	O
of	O
rat	O
serum	O
containing	O
Biejiajian	O
oral	O
liquid	O
(	O
BOL	O
)	O
,	O
a	O
decoction	O
of	O
turtle	O
shell	O
,	O
on	O
proliferation	O
of	O
rat	O
HSCs	B-NEG
,	O
and	O
to	O
explore	O
the	O
anti-hepatofibrotic	O
mechanisms	O
of	O
BOL	O
.	O

-DOCSTART-	O

To	O
clarify	O
the	O
mechanism	O
of	O
combined	O
effects	O
of	O
prednisolone	O
and	O
Shosaikoto	O
,	O
the	O
effects	O
of	O
Shosaikoto	O
on	O
the	O
blood	O
prednisolone	B-NEG
level	I-NEG
and	O
on	O
the	O
secretion	O
of	O
endogenous	B-NEG
glucocorticoid	I-NEG
(	O
corticosterone	O
)	O
were	O
investigated	O
by	O
high	O
performance	O
liquid	O
chromatography	O
.	O

-DOCSTART-	O

These	O
results	O
are	O
the	O
first	O
to	O
demonstrate	O
that	O
Guilingji	O
may	O
possess	O
an	O
antiepileptic	B-NEG
effect	I-NEG
further	O
to	O
its	O
proposed	O
antiaging	B-NEG
action	I-NEG
,	O
because	O
decreasing	O
the	O
TBARS	B-NEG
elevation	O
and	O
increasing	O
the	O
SOD	B-NEG
attenuation	O
in	O
the	O
brain	O
are	O
suggested	O
to	O
be	O
important	O
characteristics	O
of	O
antiepileptic	O
agents	O
.	O

-DOCSTART-	O

The	O
authors	O
concluded	O
that	O
debridement	O
,	O
injection	O
and	O
drug	O
covering	O
of	O
ulcer	O
surface	O
under	O
the	O
endoscopy	O
associated	O
with	O
oral	O
administration	O
of	O
Chinese	O
medicine	O
Chuanjia	O
Weidan	O
is	O
efficacious	O
in	O
treating	O
intractable	O
peptic	B-NEG
ulcer	I-NEG
.	O

-DOCSTART-	O

The	O
effect	O
of	O
herbal	O
components	O
of	O
Tokishakuyakusan	O
on	O
progestin	B-NEG
levels	O
in	O
serum	O
and	O
ovarian	O
tissue	O
from	O
rats	O
treated	O
with	O
PMS	O
and	O
hCG	O
was	O
examined	O
in	O
vivo	O
.	O

-DOCSTART-	O

Saibokuto	O
inhibited	O
in	O
vitro	O
PAF	B-NEG
production	O
in	O
a	O
dose-dependent	O
manner	O
.	O

-DOCSTART-	O

The	O
above	O
findings	O
suggested	O
Shosaikoto-induced	O
non-cardiogenic	B-NEG
pulmonary	I-NEG
edema	I-NEG
,	O
a	O
rarely	O
seen	O
disorder	O
.	O

-DOCSTART-	O

The	O
remaining	O
one	O
showed	O
a	O
rate	O
of	O
16	O
,	O
but	O
he	O
underwent	O
surgery	O
for	O
varicocele	B-NEG
and	O
treatment	O
with	O
methylcobalamin	O
and	O
Hochuekkito	O
after	O
the	O
test	O
.	O

-DOCSTART-	O

Therefore	O
,	O
Choreito	O
was	O
thought	O
to	O
be	O
an	O
effective	O
drug	O
for	O
the	O
patients	O
with	O
lower	B-NEG
urinary	I-NEG
tract	I-NEG
symptoms	I-NEG
.	O

-DOCSTART-	O

424	O
pregnant	O
women	O
(	O
MAP-2	O
greater	O
than	O
or	O
equal	O
to	O
12kPa	O
)	O
were	O
divided	O
into	O
4	O
groups	O
and	O
given	O
preventive	O
treatment	O
as	O
follows	O
(	O
1	O
)	O
The	O
control	O
group	O
,	O
122	O
women	O
,	O
no	O
drugs	O
were	O
given	O
(	O
2	O
)	O
the	O
Theragan	O
group	O
,	O
102	O
women	O
(	O
3	O
)	O
the	O
TCM	O
(	O
A	O
)	O
group	O
,	O
100	O
women	O
,	O
those	O
with	O
Liver-Kidney	B-NEG
deficiency	I-NEG
of	O
Yin	O
or	O
no	O
apparent	O
signs	O
were	O
given	O
Qiju	O
Dihuang	O
Wan	O
,	O
and	O
those	O
with	O
Spleen-Kidney	B-NEG
deficiency	I-NEG
of	O
Yang	O
were	O
given	O
Shenqiwan	O
(	O
4	O
)	O
the	O
TCM	O
(	O
B	O
)	O
group	O
,	O
100	O
women	O
,	O
were	O
given	O
Salvia	O
miltiorrhiza	O
plus	O
(	O
A	O
)	O
group	O
s	O
drugs	O
.	O

-DOCSTART-	O

Twenty-seven	O
infertile	B-NEG
women	O
with	O
hyperprolactinemia	B-NEG
were	O
treated	O
with	O
Hachimijiogan	O
(	O
5	O
.	O
0	O
to	O
10	O
.	O
0	O
g	O
day	O
)	O
,	O
Chinese	O
herbal	O
medicine	O
.	O

-DOCSTART-	O

Effects	O
of	O
Shikunshito-Kamiho	O
on	O
fecal	O
enzymes	B-NEG
and	O
formation	O
of	O
aberrant	B-NEG
crypt	I-NEG
foci	I-NEG
induced	O
by	O
1	O
,	O
2-dimethylhydrazine	O
.	O

-DOCSTART-	O

Studies	O
of	O
the	O
combined	O
use	O
of	O
steroid	O
and	O
Shosaikoto	O
,	O
one	O
of	O
the	O
Kampohozai	O
(	O
Chinese	O
traditional	O
medicine	O
)	O
,	O
on	O
pituitary	B-NEG
adrenocortical	I-NEG
axis	I-NEG
function	O
and	O
immune	B-NEG
responses	I-NEG
.	O

-DOCSTART-	O

The	O
degree	O
of	O
penetration	O
into	O
the	O
stomach	B-NEG
and	O
duodenum	B-NEG
of	O
the	O
horse	O
by	O
bot	O
fly	O
larvae	O
,	O
Gasterophilus	O
intestinalis	O
(	O
De	O
Geer	O
)	O
and	O
G	O
.	O
nasalis	O
(	O
Linnaeus	O
)	O
(	O
Diptera	O
Gasterophilidae	O
)	O
was	O
evaluated	O
.	O

-DOCSTART-	O

Adjuvant	O
therapy	O
with	O
Shosaikoto	O
and	O
Hocheukito	O
suppressed	O
INH	O
induced	O
hepato-dermatological	B-NEG
toxicosis	I-NEG
moderately	O
and	O
suppressed	O
SM	O
induced	O
high	B-NEG
fever	I-NEG
completely	O
.	O

-DOCSTART-	O

The	O
present	O
study	O
was	O
undertaken	O
to	O
identify	O
the	O
existence	O
of	O
ET	O
,	O
renin	O
,	O
angiotensin	O
II	O
and	O
the	O
binding	O
site	O
for	O
ANP	O
in	O
the	O
ovary	B-NEG
at	O
proestrus	O
and	O
examine	O
in	O
vivo	O
the	O
effects	O
of	O
herbal	O
medicines	O
Tokishakuyakusan	O
(	O
TS	O
)	O
,	O
Keishibukuryogan	O
(	O
KB	O
)	O
,	O
Shakuyakukanzoto	O
(	O
SK	O
)	O
and	O
Unkeito	O
(	O
UT	O
)	O
on	O
them	O
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
investigate	O
the	O
effect	O
of	O
choreito	O
consumption	O
(	O
500	O
mg	O
kg	O
of	O
body	O
weight	O
d	O
)	O
on	O
struvite	B-NEG
crystal	I-NEG
formation	I-NEG
and	O
signs	O
of	O
lower	B-NEG
urinary	I-NEG
tract	I-NEG
disease	I-NEG
(	O
LUTD	B-NEG
)	O
in	O
cats	O
consuming	O
a	O
commercial	O
canned	O
diet	O
with	O
0	O
.	O

5	O
added	O
inorganic	O
magnesium	O
.	O

-DOCSTART-	O

Effect	O
of	O
Qingyitang	O
on	O
activity	O
of	O
intracellular	O
Ca2	O
-Mg2	O
-ATPase	O
in	O
rats	O
with	O
acute	B-NEG
pancreatitis	I-NEG
.	O

-DOCSTART-	O

Endothelin-1	B-NEG
levels	O
are	O
not	O
influenced	O
by	O
tokishakuyakusan	O
and	O
keishibukuryogan	O
treatment	O
in	O
women	O
.	O

-DOCSTART-	O

A	O
new	O
glucose-6-phosphate	O
dehydrogenase	O
variant	O
G6PD	O
Sugao	O
(	O
826C--	O
T	O
)	O
exhibiting	O
chronic	B-NEG
hemolytic	I-NEG
anemia	I-NEG
with	O
episodes	O
of	O
hemolytic	B-NEG
crisis	I-NEG
immediately	O
after	O
birth	O
.	O

-DOCSTART-	O

Eleven	O
patients	O
with	O
lumbago	B-NEG
due	O
to	O
renal	O
ptosis	O
,	O
and	O
23	O
patients	O
with	O
stress	B-NEG
incontinence	I-NEG
were	O
treated	O
with	O
Tsumura	O
Hotyuekkito	O
(	O
Buzhongyiqitang	O
)	O
,	O
an	O
old	O
Chinese	O
prescription	O
,	O
7	O
.	O

5	O
g	O
,	O
three	O
times	O
a	O
day	O
.	O

-DOCSTART-	O

Since	O
the	O
levels	O
of	O
numerous	O
brain	O
monoamines	O
and	O
their	O
metabolites	O
such	O
as	O
norepinephrine	B-NEG
(	O
NE	B-NEG
)	O
,	O
dopamine	B-NEG
(	O
DA	B-NEG
)	O
,	O
d	O
ihydroxyphenylacetic	B-NEG
acid	I-NEG
(	O
DOPAC	O
)	O
,	O
homovanillic	B-NEG
acid	I-NEG
(	O
HVA	B-NEG
)	O
,	O
serotonin	B-NEG
(	O
5-HT	B-NEG
)	O
,	O
and	O
5-hydroxyindole	B-NEG
acetic	I-NEG
acid	I-NEG
(	O
5-HIAA	B-NEG
)	O
have	O
been	O
correlated	O
with	O
aging	O
,	O
we	O
examined	O
the	O
effects	O
of	O
Guilingji	O
powder	O
and	O
its	O
extract	O
on	O
such	O
monoamines	O
and	O
metabolites	O
in	O
the	O
cerebrum	O
and	O
the	O
cerebellum	B-NEG
of	O
mice	O
using	O
HPLC-	O
ECD	B-NEG
.	O

-DOCSTART-	O

Ninjinyoeito	O
produced	O
a	O
cell	O
proliferation	O
acceleration	O
effect	O
,	O
resulting	O
in	O
suppression	O
of	O
the	O
synthesis	O
and	O
acceleration	O
of	O
the	O
disintegration	O
of	O
endothelin	B-NEG
,	O
which	O
acts	O
as	O
a	O
vasoconstrictor	B-NEG
and	O
vasopressor	B-NEG
.	O

-DOCSTART-	O

After	O
treatment	O
with	O
baoyuantang	O
,	O
the	O
amount	B-NEG
of	I-NEG
Hb	I-NEG
was	O
increased	O
and	O
creatinine	B-NEG
decreased	O
in	O
CRF	B-NEG
patients	O
,	O
and	O
its	O
effective	O
rate	O
reached	O
83	O
.	O

3	O
.	O

-DOCSTART-	O

Sannoshashinto	O
,	O
however	O
,	O
appeared	O
to	O
accelerate	O
the	O
disappearance	O
of	O
cholesterol	B-NEG
from	O
blood	O
,	O
while	O
Daisaikoto	O
inhibited	O
the	O
cholesterol	B-NEG
absorption	O
from	O
the	O
intestine	O
.	O

-DOCSTART-	O

These	O
results	O
suggest	O
that	O
Saireito	O
does	O
not	O
stimulate	O
CRF	B-NEG
gene	I-NEG
expression	I-NEG
,	O
although	O
it	O
does	O
stimulate	O
CRF	B-NEG
release	O
,	O
which	O
in	O
turn	O
stimulates	O
POMC	B-NEG
gene	I-NEG
expression	I-NEG
in	O
the	O
anterior	O
pituitary	O
and	O
ACTH	B-NEG
release	O
.	O

-DOCSTART-	O

Taken	O
together	O
,	O
we	O
suggest	O
that	O
the	O
protective	O
effects	O
of	O
Jagamchotang	O
against	O
ischemia	B-NEG
reperfusion-induced	I-NEG
myocardial	I-NEG
damages	I-NEG
may	O
be	O
mediated	O
by	O
NO	B-NEG
production	I-NEG
during	O
ischemic	B-NEG
condition	I-NEG
.	O

-DOCSTART-	O

Shengmaiyin	O
that	O
maintains	O
interior	O
substances	O
in	O
the	O
plate	O
layer	O
bodies	O
proves	O
more	O
effective	O
than	O
Danshen-Chuanxiong	O
mixture	O
,	O
while	O
the	O
latter	O
excels	O
in	O
preventing	O
capillary	B-NEG
contraction	I-NEG
,	O
thus	O
improving	O
blood	B-NEG
circulation	I-NEG
.	O

-DOCSTART-	O

Effect	O
of	O
baoyuantang	O
on	O
erythroid	O
progenitor	O
and	O
clinical	O
observation	O
in	O
chronic	B-NEG
renal	I-NEG
failure	I-NEG
patients	O
.	O

-DOCSTART-	O

Effect	O
of	O
Hachimijiogan	O
(	O
HJ	O
)	O
on	O
dopamine	B-NEG
(	O
DA	O
)	O
,	O
serotonin	B-NEG
(	O
5-HT	O
)	O
and	O
vasoactive	B-NEG
intestinal	I-NEG
peptide	I-NEG
(	O
VIP	O
)	O
was	O
examined	O
in	O
plasma	O
and	O
hypothalamic	O
tissue	O
of	O
sulpiride-induced	O
hyperprolactinemic	O
rats	O
(	O
SHR	O
)	O
.	O

-DOCSTART-	O

Response	O
of	O
liver	O
to	O
glucocorticoid	B-NEG
is	O
altered	O
by	O
administration	O
of	O
shosaikoto	O
(	O
kampo	O
medicine	O
)	O
.	O

-DOCSTART-	O

Conclusively	O
,	O
Shosaikoto	O
prevents	O
the	O
modification	B-NEG
of	I-NEG
macrophage	I-NEG
function	O
induced	O
by	O
atherogenic	O
factors	O
,	O
which	O
is	O
probably	O
linked	O
to	O
its	O
displayed	O
anti-atherosclerotic	B-NEG
action	I-NEG
.	O

-DOCSTART-	O

Effects	O
of	O
Kamikihito	O
,	O
a	O
traditional	O
Chinese	O
medicine	O
,	O
on	O
neurotransmitter	B-NEG
receptor	I-NEG
binding	I-NEG
in	O
the	O
aged	O
rat	O
brain	O
determined	O
by	O
in	O
vitro	O
autoradiography	O
(	O
2	O
)	O
changes	O
in	O
GABAA	B-NEG
and	I-NEG
benzodiazepine	I-NEG
receptor	I-NEG
binding	I-NEG
.	O

-DOCSTART-	O

Immunoregulation	O
of	O
Youguiyin	O
,	O
Sijunzitang	O
,	O
Taohong	O
Siwutang	O
in	O
treating	O
patients	O
with	O
deficiency	O
of	O
kidney	B-NEG
,	O
spleen	B-NEG
and	O
blood	B-NEG
stasis	I-NEG
syndrome	I-NEG
.	O

-DOCSTART-	O

RESULTS	O
Two	O
hours	O
after	O
adding	O
serum	O
with	O
ASA	O
,	O
the	O
decrease	O
of	O
sperm	B-NEG
motility	I-NEG
was	O
significantly	O
reduced	O
from	O
25	O
.	O

1	O
(	O
92	O
.	O
8	O
--	O
67	O
.	O
7	O
)	O
to	O
12	O
.	O

5	O
(	O
92	O
.	O
9	O
--	O
80	O
.	O
6	O
)	O
by	O
adding	O
Hochuekkito	O
.	O

-DOCSTART-	O

Sishengtang	O
decoction	O
in	O
alleviation	O
of	O
toxic	B-NEG
and	O
side	O
effects	O
of	O
transarterial	O
embolization	O
.	O

-DOCSTART-	O

Asthmatic	O
children	O
and	O
Chinese	O
medicine	O
.	O

I	O
.	O

Effect	O
of	O
Shoseiryuto	O
on	O
asthmatic	B-NEG
children	O
and	O
on	O
guinea	O
pig	O
tracheal	B-NEG
smooth	I-NEG
muscle	I-NEG
.	O

-DOCSTART-	O

To	O
study	O
its	O
clinical	O
effect	O
,	O
Tsumura	O
Seishinrenshiin	O
,	O
was	O
administered	O
to	O
male	O
patients	O
of	O
chronic	B-NEG
prostatitis	I-NEG
and	O
urethritis	B-NEG
with	O
various	O
equivocal	O
complaints	O
of	O
the	O
lower	B-NEG
urinary	I-NEG
tract	I-NEG
and	O
female	O
patients	O
complaining	O
of	O
cystitoid	O
symptoms	O
inspite	O
of	O
normal	O
urine	O
.	O

-DOCSTART-	O

In	O
addition	O
,	O
the	O
modulatory	O
effects	O
of	O
Samultang	O
on	O
LPS	B-NEG
PMA	B-NEG
-induced	O
cytotoxicity	B-NEG
and	O
NO	B-NEG
production	I-NEG
could	O
be	O
mimicked	O
by	O
exogenous	O
treatments	O
of	O
N	O
(	O
G	O
)	O
MMA	O
,	O
a	O
nitric	O
oxide	O
synthase	O
(	O
NOS	O
)	O
inhibitor	O
,	O
and	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
,	O
a	O
strong	O
NF-kappaB	O
inhibitor	O
.	O

-DOCSTART-	O

A	O
sample	O
of	O
40	O
men	O
and	O
40	O
women	O
patients	O
with	O
extreme	O
dental	B-NEG
anxiety	I-NEG
were	O
initially	O
evaluated	O
with	O
Dental	O
Anxiety	O
Scale	O
(	O
DAS	O
)	O
,	O
Trait	O
Anxiety	O
Inventory	O
(	O
STAI-T	O
)	O
and	O
Geer	O
Fear	O
Scale	O
(	O
GFS	O
)	O
.	O

-DOCSTART-	O

Although	O
not	O
showing	O
anti-hypercholesterolemic	B-NEG
action	I-NEG
against	O
ICR	O
mice	O
,	O
Shosaikoto	O
,	O
a	O
Kampo	O
medicine	O
,	O
partially	O
prevented	O
the	O
reduction	B-NEG
of	I-NEG
NO	I-NEG
and	I-NEG
IL-1	I-NEG
productions	I-NEG
induced	O
by	O
the	O
feeding	O
of	O
cholesterol-enriched	O
diet	O
,	O
and	O
completely	O
released	O
the	O
reduction	B-NEG
of	I-NEG
PGE	I-NEG
(	I-NEG
2	I-NEG
)	I-NEG
production	I-NEG
.	O

-DOCSTART-	O

Furthermore	O
,	O
although	O
oxidized	O
low	O
density	O
lipoprotein	O
(	O
LDL	O
)	O
and	O
lysophosphatidylcholine	O
(	O
LPC	O
)	O
reduced	O
NO	O
production	O
,	O
macrophages	O
prepared	O
from	O
mice	O
treated	O
with	O
Shosaikoto	O
at	O
a	O
dose	O
of	O
1	O
.	O

2	O
g	O
kg	O
d	O
restored	O
the	O
reduced	O
NO	B-NEG
production	I-NEG
by	O
them	O
as	O
well	O
as	O
by	O
hypercholesterolemia	B-NEG
.	O

-DOCSTART-	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
mechanism	O
by	O
which	O
Jagamchotang	O
rescues	O
myocardial	B-NEG
cells	I-NEG
from	O
ischemic	B-NEG
damages	I-NEG
.	O

-DOCSTART-	O

Successful	O
treatment	O
of	O
a	O
hyperprolactinemic	O
infertile	B-NEG
woman	O
with	O
a	O
pituitary	B-NEG
microadenoma	I-NEG
using	O
hachimijiogan	O
.	O

-DOCSTART-	O

Injection	O
of	O
10	O
IU	O
pregnant	O
mare	O
serum	O
gonadotropin	O
(	O
PMS	O
)	O
on	O
day	O
27	O
of	O
age	O
gradually	O
increased	O
DNA	O
polymerase	O
alpha	O
activity	O
in	O
uteri	O
,	O
while	O
concomitant	O
treatment	O
with	O
PMS	O
and	O
200	O
micrograms	O
Tokishakuyakusan	O
(	O
TS	O
)	O
,	O
Keishibukuryogan	O
(	O
KB	O
)	O
or	O
Unkeito	O
(	O
UT	O
)	O
suppressed	O
the	O
enzyme	B-NEG
activity	I-NEG
,	O
with	O
a	O
most	O
remarkable	O
effect	O
of	O
KB	O
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
observe	O
the	O
changes	O
of	O
oxidation	O
and	O
hepatic	O
cells	O
apoptosis	O
in	O
the	O
wet-heat	B-NEG
syndrome	I-NEG
rat	O
model	O
,	O
and	O
the	O
effect	O
of	O
qingxiangsan	O
on	O
inhibiting	O
oxidation	O
and	O
hepatic	O
cells	O
apoptosis	O
.	O

-DOCSTART-	O

In	O
the	O
group	O
fed	O
the	O
diet	O
supplemented	O
with	O
Wulingsan	O
,	O
the	O
severity	O
of	O
calcinosis	B-NEG
in	O
the	O
corticomedullary	O
junction	O
was	O
only	O
slight	O
.	O

-DOCSTART-	O

Saibokuto	O
also	O
suppressed	O
the	O
induced	O
IL2	B-NEG
responsiveness	I-NEG
of	O
lymphocytes	O
from	O
the	O
same	O
patients	O
on	O
stimulation	O
wit	O
PPD	O
,	O
but	O
not	O
with	O
Con	O
A	O
.	O

-DOCSTART-	O

However	O
,	O
suanzaorentang	O
,	O
but	O
not	O
diazepam	O
,	O
improved	O
the	O
psychomotor	B-NEG
performance	I-NEG
during	O
the	O
daytime	O
.	O

-DOCSTART-	O

Moreover	O
,	O
Shosaikoto	O
did	O
not	O
affect	O
the	O
induction	O
of	O
TAT	B-NEG
activity	I-NEG
by	O
butyryl-adenosine	O
3	O
,	O
5	O
-cyclic	O
monophosphate	O
.	O

-DOCSTART-	O

These	O
results	O
suggest	O
that	O
Hachimijiogan	O
possesses	O
a	O
wide-ranging	O
pharmacological	O
profile	O
in	O
anti-amnesic	B-NEG
actions	I-NEG
and	O
that	O
its	O
anti-amnesic	O
activities	O
may	O
be	O
related	O
to	O
the	O
cholinergic	O
neuronal	O
system	O
.	O

-DOCSTART-	O

Permethrin-resistant	O
colonies	O
of	O
Pediculus	B-NEG
capitis	I-NEG
(	O
De	O
Geer	O
)	O
from	O
Buenos	O
Aires	O
were	O
used	O
to	O
establish	O
a	O
resistance	O
profile	O
and	O
to	O
examine	O
resistance	O
mechanisms	O
.	O

-DOCSTART-	O

Hwansodan	O
protects	O
PC12	B-NEG
cells	I-NEG
against	O
serum-deprivation-induced	O
apoptosis	B-NEG
via	O
a	O
mechanism	O
involving	O
Ras	B-NEG
and	O
mitogen-activated	B-NEG
protein	I-NEG
(	O
MAP	B-NEG
)	O
kinase	O
pathway	O
.	O

-DOCSTART-	O

Effect	O
of	O
reduqing	O
on	O
HL-60	B-NEG
cells	I-NEG
in	O
secreting	O
tumor	B-NEG
necrosis	I-NEG
factor	I-NEG
alpha	I-NEG
production	I-NEG
and	O
on	O
TNF	B-NEG
alpha	I-NEG
converting	I-NEG
enzyme	I-NEG
mRNA	I-NEG
expression	I-NEG
.	O

-DOCSTART-	O

Furthermore	O
,	O
we	O
found	O
that	O
Maimendongtang	O
significantly	O
restored	O
HNE-induced	O
increases	O
in	O
DNA	B-NEG
,	O
fucose	B-NEG
and	O
protein	B-NEG
contents	O
of	O
airway	B-NEG
surface	I-NEG
fluid	I-NEG
(	O
ASF	B-NEG
)	O
,	O
whereas	O
only	O
Maimendongtang	O
itself	O
significantly	O
decreased	O
the	O
protein	B-NEG
content	O
.	O

-DOCSTART-	O

Clinical	O
study	O
on	O
effect	O
of	O
jinshisan	O
on	O
dissolution	O
of	O
extra-	O
intrahepatic	O
biliary	B-NEG
stones	I-NEG
.	O

-DOCSTART-	O

In	O
the	O
present	O
study	O
we	O
conducted	O
rat	O
liver	O
perfusion	O
using	O
the	O
HMG	O
Co	O
A	O
reductase	O
inhibitor	O
(	O
CS-514	O
)	O
and	O
Kampo	O
medicine	O
(	O
Daisaikoto	O
)	O
to	O
elucidate	O
the	O
mechanism	O
of	O
the	O
effect	O
of	O
dietary	O
cholesterol	B-NEG
on	O
hepatic	O
lipoprotein	O
and	O
apolipoprotein	O
synthesis	O
.	O

-DOCSTART-	O

Tokishakuyakusan	O
effect	O
on	O
DNA	B-NEG
polymerase	I-NEG
alpha	I-NEG
activity	I-NEG
in	O
relationship	O
to	O
DNA	B-NEG
synthesis	I-NEG
before	O
and	O
or	O
after	O
the	O
LH	O
FSH	O
surge	O
in	O
rats	O
.	O

-DOCSTART-	O

Effects	O
of	O
oral	O
administration	O
of	O
Juzentaihoto	O
,	O
a	O
herb	O
drug	O
,	O
on	O
the	O
toxic	O
side	O
effects	O
of	O
cis-diammine	O
dichloroplatinum	O
(	O
CDDP	O
)	O
and	O
combination	O
effects	O
with	O
CDDP	O
on	O
murine	O
bladder	B-NEG
tumor	I-NEG
(	O
MBT	O
2	O
)	O
were	O
studied	O
using	O
C3H	O
He	O
male	O
mice	O
.	O

-DOCSTART-	O

Sinitang	O
significantly	O
prevented	O
the	O
decrease	B-NEG
of	I-NEG
mean	I-NEG
arterial	I-NEG
pressure	I-NEG
,	O
controlled	O
the	O
reduced	O
velocity	O
and	O
also	O
,	O
apparently	O
inhibited	O
the	O
leukocyte	B-NEG
extravasation	I-NEG
across	O
venules	O
.	O

-DOCSTART-	O

In	O
the	O
presence	O
of	O
control	O
LDL	O
or	O
in	O
the	O
absence	O
of	O
LDL	O
,	O
incorporation	O
of	O
3H	O
oleic	O
acid	O
into	O
chlesteryl	O
oleate	O
was	O
significantly	O
reduced	O
in	O
Shosaikoto	O
treated	O
macrophages	B-NEG
.	O

-DOCSTART-	O

Hachimijiogan	O
treatment	O
is	O
effective	O
in	O
the	O
management	O
of	O
infertile	B-NEG
women	I-NEG
with	O
hyperprolactinemia	B-NEG
or	O
bromocriptine-resistant	O
hyperprolactinemia	O
.	O

-DOCSTART-	O

The	O
ancient	O
Chinese	O
remedy	O
Suanzaorentang	O
was	O
originally	O
described	O
in	O
Kin-Kue-Yao-Lueh	O
for	O
patients	O
with	O
weakness	B-NEG
,	O
irritability	B-NEG
and	O
insomnia	B-NEG
.	O

-DOCSTART-	O

These	O
data	O
suggested	O
that	O
the	O
anti-atherosclerotic	O
action	O
shown	O
by	O
Shosaikoto	O
resulted	O
partly	O
from	O
the	O
suppression	O
of	O
the	O
enhanced	O
adherence	B-NEG
characteristic	I-NEG
of	I-NEG
hypercholesterolemia	I-NEG
.	O

-DOCSTART-	O

SIGO	O
Study	O
Group	O
of	O
HIV	B-NEG
Infection	O
in	O
Pregnancy	O
.	O

-DOCSTART-	O

We	O
studied	O
the	O
anxiolytic	O
and	O
psychomotor	O
effects	O
of	O
the	O
ancient	O
Chinese	O
formula	O
of	O
Suanzaorentang	O
,	O
and	O
found	O
that	O
it	O
improved	O
mood	B-NEG
,	O
decreased	O
the	O
accompanying	O
sympathetic	B-NEG
symptoms	I-NEG
and	O
improved	O
psychomotor	B-NEG
performance	I-NEG
during	O
the	O
day	O
.	O

-DOCSTART-	O

We	O
have	O
previously	O
demonstrated	O
that	O
transfected	O
hepatocellular	B-NEG
carcinoma	I-NEG
cells	O
(	O
Hepa1-6	O
)	O
with	O
one	O
copy	O
(	O
pAGO	O
)	O
and	O
two	O
copies	O
(	O
pYED	O
)	O
of	O
the	O
HSVtk	O
gene	O
,	O
using	O
liposomes	O
,	O
induced	O
cell	O
death	O
of	O
untransfected	O
cells	O
in	O
the	O
presence	O
of	O
ganciclovir	O
(	O
GCV	O
)	O
.	O

-DOCSTART-	O

As	O
a	O
result	O
,	O
the	O
maximum	O
cell	O
density	O
obtained	O
after	O
the	O
addition	O
of	O
Ninjinyoeito	O
was	O
found	O
to	O
be	O
400	O
ng	O
ml	O
,	O
and	O
its	O
inhibitory	O
effect	O
on	O
the	O
development	O
of	O
endothelial	B-NEG
injury	I-NEG
was	O
also	O
observed	O
.	O

-DOCSTART-	O

Hochuekkito	O
increased	O
the	O
mitogenic	O
activity	O
of	O
LPS	B-NEG
,	O
Con	B-NEG
A	I-NEG
,	O
PMA	B-NEG
and	O
PHA	B-NEG
.	O

-DOCSTART-	O

Moreover	O
,	O
300	O
mg	O
kg	O
or	O
1	O
g	O
kg	O
of	O
Maimendongtang	O
markedly	O
attenuated	O
human	B-NEG
neutrophil	I-NEG
elastase	I-NEG
(	O
HNE	O
)	O
or	O
DNA-induced	O
decrease	O
in	O
MCTV	B-NEG
although	O
100	O
mg	O
kg	O
of	O
Maimendongtang	O
had	O
little	O
effect	O
.	O

-DOCSTART-	O

Hachimijiogan	O
was	O
effective	O
in	O
65	O
of	O
66	O
cases	O
with	O
abnormal	O
discharge	O
,	O
10	O
of	O
11	O
with	O
pruritus	B-NEG
vaginae	O
and	O
60	O
of	O
62	O
with	O
subepithelial	B-NEG
hemorrhage	I-NEG
.	O

-DOCSTART-	O

Effects	O
of	O
Guilingji	O
on	O
brain	B-NEG
monoamines	O
and	O
their	O
metabolites	O
in	O
mice	O
.	O

-DOCSTART-	O

Moreover	O
,	O
frequency	O
and	O
severity	O
of	O
hematuria	B-NEG
were	O
significantly	O
decreased	O
in	O
cats	O
fed	O
the	O
choreito-containing	O
diet	O
.	O

-DOCSTART-	O

Studies	O
on	O
the	O
suanzaorentang	O
in	O
the	O
treatment	O
of	O
anxiety	B-NEG
.	O

-DOCSTART-	O

pAGO-transformed	O
KY895	O
cells	O
exhibited	O
partially	O
restored	O
ability	O
to	O
incorporate	O
3H	O
dThd	O
into	O
DNA	O
and	O
an	O
HSv-1-specific	B-NEG
TK	I-NEG
activity	I-NEG
.	O

-DOCSTART-	O

Effects	O
of	O
Zuoguiwan	O
(	O
ZGW	O
,	O
a	O
prescription	O
for	O
reinforcing	O
Kidney	O
Yin	O
)	O
on	O
early	B-NEG
embryonic	I-NEG
development	I-NEG
were	O
observed	O
by	O
using	O
embryonic	O
developmental	O
retardation	O
model	O
of	O
mice	O
formed	O
by	O
alcohol	O
.	O

-DOCSTART-	O

To	O
examine	O
the	O
possible	O
effects	O
of	O
Tokishakuyakusan	O
(	O
TS	O
)	O
on	O
steroidogenesis	B-NEG
by	O
preovulatory	O
follicles	O
at	O
the	O
cell	O
level	O
,	O
the	O
expressed	O
granulosa	O
cells	O
and	O
remaining	O
portion	O
of	O
follicles	O
from	O
pregnant	O
mare	O
s	O
serum	O
gonadotropin	O
(	O
PMS	O
)	O
-treated	O
immature	O
rats	O
were	O
incubated	O
in	O
vitro	O
with	O
increasing	O
concentrations	O
of	O
TS	O
for	O
3	O
h	O
.	O

-DOCSTART-	O

We	O
treated	O
30	O
patients	O
having	O
37	O
urinary	B-NEG
calculi	I-NEG
in	O
all	O
,	O
with	O
Choreito	O
(	O
5	O
g	O
day	O
)	O
and	O
Shakuyakukanzoto	O
(	O
5	O
g	O
day	O
)	O
to	O
study	O
whether	O
these	O
medicines	O
hastened	O
spontaneous	O
calculus	B-NEG
excretion	I-NEG
.	O

-DOCSTART-	O

On	O
the	O
other	O
hand	O
,	O
the	O
administration	O
of	O
Shosaikoto	O
,	O
1	O
.	O

2	O
g	O
kg	O
p	O
.	O
o	O
.	O
,	O
for	O
7	O
d	O
reduced	O
the	O
number	O
of	O
hemolytic	B-NEG
plaque	I-NEG
forming	I-NEG
cells	I-NEG
(	O
HPFC	O
)	O
in	O
spleen	O
cells	O
.	O

-DOCSTART-	O

Hachimijiogan	O
produces	O
testosterone	B-NEG
in	O
adult	O
rat	O
testes	O
.	O

-DOCSTART-	O

The	O
clinical	O
evaluation	O
of	O
hochuekkito	O
for	O
symptoms	O
of	O
malignant	B-NEG
neoplasm	I-NEG
patients	O
.	O

-DOCSTART-	O

METHODS	O
Using	O
cytobiologic	O
and	O
molecular	O
biologic	O
technique	O
to	O
observe	O
the	O
effects	O
of	O
Reduqing	O
on	O
HL-60	B-NEG
cells	I-NEG
in	O
producing	O
inflammatory	O
cytokine	O
secreting	O
TNF	O
alpha	O
(	O
sTNF	O
alpha	O
)	O
and	O
on	O
mRNA	O
expression	O
of	O
TNF	B-NEG
alpha	I-NEG
converting	I-NEG
enzyme	I-NEG
(	O
TACE	B-NEG
)	O
.	O

-DOCSTART-	O

Thus	O
,	O
Saibokuto	O
enhances	O
ciliary	B-NEG
motility	I-NEG
probably	O
through	O
the	O
synthesis	O
of	O
cyclooxygenase	B-NEG
products	I-NEG
and	O
cyclic	B-NEG
AMP	I-NEG
.	O

-DOCSTART-	O

Shosaikoto	O
,	O
a	O
Kampo	O
medicine	O
used	O
clinically	O
to	O
treat	O
patients	O
with	O
chronic	B-NEG
hepatitis	I-NEG
or	O
cirrhosis	B-NEG
in	O
Japan	O
,	O
displays	O
immunoregulatory	O
effects	O
,	O
especially	O
on	O
macrophage	O
functions	O
.	O

-DOCSTART-	O

Studies	O
were	O
conducted	O
to	O
determine	O
the	O
ability	O
of	O
Aedes	O
excrucians	O
(	O
Walker	O
)	O
,	O
Ae	O
.	O
cinereus	O
Meigen	O
,	O
and	O
Ae	O
.	O
communis	O
(	O
De	O
Geer	O
)	O
group	O
mosquitoes	O
,	O
collected	O
in	O
an	O
Ockelbo	B-NEG
(	I-NEG
OCK	I-NEG
)	I-NEG
virus	I-NEG
enzootic	O
area	O
in	O
central	O
Sweden	O
,	O
to	O
transmit	O
this	O
virus	O
.	O

-DOCSTART-	O

Hachimijiogan	O
changes	O
serum	O
hormonal	O
circumstance	O
and	O
improves	O
spermatogenesis	B-NEG
in	O
oligozoospermic	O
men	O
.	O

-DOCSTART-	O

Therapeutic	O
experiences	O
of	O
seishinrenshiin	O
in	O
patients	O
with	O
equivocal	O
complaints	O
of	O
the	O
lower	B-NEG
urinary	I-NEG
tract	I-NEG
.	O

-DOCSTART-	O

Furthermore	O
,	O
although	O
monocytes	O
from	O
hypercholesterolemic	O
rabbits	O
increased	O
in	O
adherence	O
to	O
endothelial	O
cells	O
even	O
without	O
lipopolysaccharide	O
(	O
LPS	O
)	O
activation	O
,	O
Shosaikoto	O
treatment	O
reduced	O
the	O
enhanced	O
adherence	B-NEG
observed	O
in	O
monocytes	O
from	O
hypercholesterolemic	O
rabbits	O
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
observe	O
the	O
effect	O
of	O
herbal	O
eye	O
drop	O
Reduqing	O
(	O
clearing	O
toxic	O
heat	O
)	O
on	O
herpes	B-NEG
simplex	I-NEG
virus	I-NEG
(	O
HSV	B-NEG
)	O
on	O
the	O
cytopathic	O
effect	O
in	O
cell	O
culture	O
in	O
vitro	O
.	O

-DOCSTART-	O

To	O
learn	O
whether	O
interferon	O
could	O
prevent	O
the	O
biochemical	O
transformations	O
induced	O
by	O
cloned	O
herpesvirus	B-NEG
thymidine	I-NEG
kinase	I-NEG
(	I-NEG
TK	I-NEG
)	I-NEG
genes	I-NEG
,	O
LM	O
(	O
TK-	O
)	O
mouse	O
fibroblast	O
cultures	O
were	O
pretreated	O
for	O
24	O
h	O
with	O
2	O
.	O

4-40	O
international	O
units	O
(	O
I	O
.	O
U	O
.	O
)	O
ml	O
mouse	O
alpha	O
beta	O
interferon	O
,	O
and	O
subsequently	O
transformed	O
to	O
the	O
TK	O
phenotype	O
with	O
recombinant	O
plasmids	O
containing	O
the	O
herpes	B-NEG
simplex	I-NEG
virus	I-NEG
type	I-NEG
1	I-NEG
(	I-NEG
HSV-1	I-NEG
)	I-NEG
TK	I-NEG
gene	I-NEG
(	O
pAGO	O
and	O
pMH110	O
)	O
and	O
the	O
marmoset	B-NEG
herpesvirus	I-NEG
(	I-NEG
MarHV	I-NEG
)	I-NEG
TK	I-NEG
gene	I-NEG
(	O
pMAR035	O
)	O
.	O

-DOCSTART-	O

This	O
clinical	O
study	O
shows	O
that	O
CT-guided	O
stereotactic	O
biopsy	O
of	O
nonpolar	O
tumors	B-NEG
in	O
the	O
dominant	O
hemisphere	O
using	O
the	O
Brown-Roberts-Wells	O
system	O
and	O
the	O
Sedan-Nashold	O
biopsy	O
cannula	O
carries	O
a	O
9	O
risk	O
(	O
95	O
confidence	O
intervals	O
0-26	O
)	O
of	O
impairing	O
language	O
functions	O
if	O
the	O
patient	O
is	O
not	O
dysphasic	O
preoperatively	O
.	O

-DOCSTART-	O

The	O
combined	O
effects	O
of	O
Shosaikoto	O
,	O
one	O
of	O
the	O
Kampohozai	O
(	O
Chinese	O
traditional	O
medicine	O
)	O
,	O
and	O
prednisolone	O
were	O
examined	O
for	O
suppressive	O
actions	O
on	O
pituitary	B-NEG
adrenocortical	I-NEG
axis	I-NEG
function	O
and	O
immune	B-NEG
response	I-NEG
induced	O
by	O
prednisolone	O
using	O
rats	O
and	O
mice	O
.	O

-DOCSTART-	O

Thirty	O
infertile	B-NEG
male	I-NEG
patients	O
were	O
orally	O
given	O
Goshajinkigan	O
at	O
a	O
daily	O
dose	O
of	O
5	O
.	O

0	O
g	O
for	O
three	O
months	O
or	O
more	O
.	O

-DOCSTART-	O

Effect	O
of	O
hachimijiogan	O
,	O
an	O
oriental	O
herbal	O
medicinal	O
mixture	O
,	O
on	O
experimental	O
amnesia	B-NEG
in	O
mice	O
.	O

-DOCSTART-	O

The	O
decrease	O
of	O
7S	O
HA	B-NEG
titer	O
of	O
the	O
serum	O
by	O
the	O
treatment	O
with	O
prednisolone	O
,	O
0	O
.	O

01	O
g	O
kg	O
s	O
.	O

c	O
.	O
,	O
was	O
also	O
inhibited	O
by	O
the	O
combination	O
with	O
Shosaikoto	O
,	O
1	O
.	O

2	O
g	O
kg	O
p	O
.	O
o	O
.	O

-DOCSTART-	O

A	O
controlled	O
comparative	O
double-blind	O
clinical	O
trial	O
was	O
set	O
up	O
to	O
assess	O
the	O
anxiolytic	B-NEG
effect	I-NEG
of	O
suanzaorentang	O
.	O

-DOCSTART-	O

In	O
addition	O
,	O
treatment	O
with	O
shosaikoto	O
suppressed	O
intimal	B-NEG
hyperplasia	I-NEG
in	O
apoE-deficient	O
mice	O
fed	O
a	O
cholesterol-enriched	O
diet	O
for	O
nine	O
weeks	O
.	O

-DOCSTART-	O

The	O
effects	O
of	O
Shengmaisan	O
with	O
Astragalus	O
membranaceus	O
(	O
SMAM	O
)	O
on	O
anti-tumor	B-NEG
activity	I-NEG
of	O
LAK	O
cells	O
with	O
the	O
3H	O
release	O
assay	O
were	O
studied	O
.	O

-DOCSTART-	O

Experiments	O
were	O
performed	O
for	O
investigating	O
the	O
effects	O
of	O
Injectio	O
Reduqing	O
(	O
RDQ	O
)	O
on	O
plasma	O
i	O
nterleukin-8	B-NEG
(	I-NEG
IL-8	I-NEG
)	I-NEG
,	O
NO2-	B-NEG
NO3-	I-NEG
,	O
complement	B-NEG
5a	I-NEG
(	O
C5a	B-NEG
)	O
and	O
p	O
olymorphonuclear	B-NEG
neutrophilic	I-NEG
leukocyte	I-NEG
(	O
PMN	B-NEG
)	O
Chemotaxis	O
Index	O
(	O
CI	O
)	O
in	O
rabbits	O
with	O
endotoxin-induced	O
disseminated	B-NEG
intravascular	I-NEG
coagulation	I-NEG
(	O
DIC	B-NEG
)	O
.	O

-DOCSTART-	O

The	O
dose-response	O
for	O
the	O
induction	O
of	O
acentric	B-NEG
chromosome	I-NEG
fragments	O
was	O
determined	O
in	O
neuroblasts	O
of	O
the	O
grasshopper	O
embryo	O
(	O
Chortophaga	O
viridifasciata	O
De	O
Geer	O
,	O
Orthoptera	O
Acrididae	O
)	O
exposed	O
in	O
vitro	O
to	O
four	O
direct-acting	O
chemical	O
known	O
to	O
be	O
mutagenic	O
,	O
clastogenic	O
,	O
and	O
carcinogenic	O
4-nitroquinoline-1-oxide	O
(	O
4NQO	O
)	O
,	O
N-methyl-N-nitro-N-nitrosoguanidine	O
(	O
MNNG	O
)	O
,	O
Adriamycin	O
(	O
ADM	O
)	O
,	O
and	O
bleomycin	O
(	O
BLM	O
)	O
.	O

-DOCSTART-	O

These	O
results	O
suggest	O
that	O
administration	O
of	O
TSUMURA-Goshajinkigan	O
is	O
effective	O
as	O
therapy	O
for	O
male	B-NEG
infertility	I-NEG
,	O
but	O
how	O
this	O
drug	O
may	O
be	O
involved	O
in	O
promoting	O
fertility	O
should	O
be	O
investigated	O
in	O
future	O
.	O

-DOCSTART-	O

Oral	O
administration	O
of	O
shosaikoto	O
influences	O
the	O
synthesis	O
of	O
humoral	O
factors	O
such	O
as	O
the	O
interleukins	B-NEG
,	O
nitric	B-NEG
oxide	I-NEG
and	O
prostaglandins	B-NEG
in	O
macrophages	O
.	O

-DOCSTART-	O

NG-monomethyi-L-argine	O
(	O
NGMMA	O
)	O
,	O
a	O
specific	O
inhibitor	O
of	O
nitric	O
oxide	O
synthase	O
(	O
NOS	O
)	O
,	O
significantly	O
blocks	O
the	O
protective	O
effects	O
of	O
Jagamchotang	O
on	O
the	O
cells	B-NEG
after	O
ischemia	B-NEG
reperfusion	I-NEG
.	O

-DOCSTART-	O

According	O
to	O
traditional	O
Oriental	O
philosophy	O
,	O
Hwanglyun-Haedok-Tang	O
(	O
HH-Tang	O
)	O
is	O
a	O
prescription	O
for	O
heat	B-NEG
clearing	O
of	O
the	O
organism	O
.	O

-DOCSTART-	O

We	O
present	O
a	O
6-year	O
experience	O
on	O
307	O
stereotactic	O
biopsy	O
specimens	O
of	O
the	O
central	B-NEG
nervous	I-NEG
system	I-NEG
using	O
Leksell	O
s	O
and	O
Talairach	O
s	O
systems	O
independently	O
and	O
either	O
Leksell	O
or	O
Sedan	O
needles	O
.	O

-DOCSTART-	O

Saireito	O
,	O
a	O
saiko	O
agent	O
(	O
a	O
Chinese	O
herbal	O
drug	O
)	O
,	O
increases	O
the	O
synthesis	O
and	O
secretion	O
of	O
ACTH	B-NEG
by	O
stimulating	O
hypothalamic	O
CRH	B-NEG
release	O
.	O

-DOCSTART-	O

This	O
study	O
was	O
to	O
compare	O
the	O
effects	O
of	O
Pingandan	O
with	O
those	O
of	O
scopolamine	O
and	O
dramamine	O
on	O
motion	B-NEG
sickness	I-NEG
(	O
MS	O
)	O
and	O
nystagmus	B-NEG
.	O

-DOCSTART-	O

In	O
the	O
case	O
of	O
combined	O
use	O
,	O
Shosaikoto	O
,	O
0	O
.	O

12	O
and	O
1	O
.	O

2	O
g	O
kg	O
p	O
.	O
o	O
.	O
,	O
inhibited	O
the	O
decrease	B-NEG
of	I-NEG
blood	I-NEG
corticosterone	I-NEG
level	I-NEG
induced	O
by	O
the	O
treatment	O
with	O
prednisolone	O
,	O
0	O
.	O

004	O
g	O
kg	O
p	O
.	O
o	O
.	O
,	O
and	O
Shosaikoto	O
,	O
1	O
.	O

2	O
g	O
kg	O
p	O
.	O
o	O
.	O
,	O
inhibited	O
the	O
decrease	O
of	O
blood	O
corticosterone	O
level	O
induced	O
by	O
the	O
treatment	O
with	O
prednisolone	O
,	O
0	O
.	O

016	O
g	O
kg	O
p	O
.	O
o	O
.	O

-DOCSTART-	O

METHODS	O
BALB	O
c	O
mouse	O
models	O
of	O
colonic	B-NEG
adenocarcinoma	I-NEG
with	O
liver	O
metastases	O
were	O
established	O
by	O
intrasplenic	O
injection	O
of	O
colonic	O
adenocarcinoma	O
cells	O
(	O
CT26	O
)	O
to	O
receive	O
treatment	O
with	O
the	O
three	O
representative	O
classical	O
circulation-promoting	B-NEG
and	O
blood	B-NEG
stasis-removing	I-NEG
prescriptions	O
of	O
traditional	O
Chinese	O
medicine	O
,	O
namely	O
Guizhifuling	O
pills	O
,	O
Didang	O
Tang	O
and	O
Danshenyin	O
,	O
respectively	O
.	O

-DOCSTART-	O

The	O
H-DNA	O
repeat	O
unit	O
of	O
Herpesvirus	B-NEG
saimiri	O
strain	O
11	O
was	O
cloned	O
in	O
plasmid	O
vector	O
pAGO	O
,	O
and	O
the	O
nucleotide	O
sequence	O
was	O
determined	O
by	O
the	O
dideoxy	O
chain	O
termination	O
method	O
.	O

-DOCSTART-	O

Asthmatic	B-NEG
children	O
and	O
Chinese	O
medicine	O
.	O

Scientific	O
study	O
of	O
shoseiryuto	O
and	O
saibokuto	O
.	O

-DOCSTART-	O

Hachimijiogan	O
and	O
Tokishakuyakusan	O
enhance	O
deoxyribonucleic	B-NEG
acid	I-NEG
alpha-nucleotidyltransferase	I-NEG
activity	I-NEG
in	O
relationship	O
to	O
DNA	O
synthesis	O
by	O
ovarian	O
follicles	O
via	O
a	O
cyclic	O
AMP	O
system	O
.	O

-DOCSTART-	O

Effect	O
of	O
rat	O
serum	O
containing	O
Biejiajian	O
oral	O
liquid	O
on	O
proliferation	O
of	O
rat	O
hepatic	B-NEG
stellate	I-NEG
cells	I-NEG
.	O

-DOCSTART-	O

Suanzaorentang	O
in	O
cardiac	O
patients	O
with	O
anxiety	B-NEG
.	O

-DOCSTART-	O

The	O
action	O
of	O
Saikokeishito	O
was	O
suppressed	O
weakly	O
by	O
treatment	O
with	O
progesterone	B-NEG
or	O
17	B-NEG
alpha-methyltestosterone	I-NEG
,	O
but	O
not	O
blocked	O
by	O
treatment	O
with	O
actinomycin	B-NEG
D	I-NEG
or	O
cycloheximide	B-NEG
.	O

-DOCSTART-	O

Hormonal	B-NEG
imbalance	I-NEG
in	O
both	O
sexes	O
may	O
be	O
treated	O
with	O
Chinese	O
herbal	O
mixtures	O
such	O
as	O
Hachimijiogan	O
,	O
herbs	O
such	O
as	O
Vitex	O
agnus-castus	O
,	O
or	O
a	O
blend	O
of	O
essential	O
oils	O
designed	O
to	O
treat	O
amenorrhoea	B-NEG
or	O
scanty	B-NEG
irregular	I-NEG
periods	I-NEG
.	O

-DOCSTART-	O

RESULTS	O
Sijunzitang	O
could	O
reduce	O
the	O
level	O
of	O
CIC	B-NEG
(	O
P	O
0	O
.	O
01	O
)	O
,	O
raise	O
the	O
activity	B-NEG
of	I-NEG
NK	I-NEG
cell	I-NEG
and	O
LRT	B-NEG
(	O
P	O
0	O
.	O
01	O
)	O
of	O
the	O
patients	O
with	O
deficiency	B-NEG
of	I-NEG
Spleen	I-NEG
syndrome	I-NEG
the	O
same	O
did	O
the	O
Youguiyin	O
to	O
that	O
of	O
patients	O
with	O
deficiency	B-NEG
of	I-NEG
Kidney	I-NEG
syndrome	I-NEG
.	O

-DOCSTART-	O

Clinical	O
observation	O
on	O
effect	O
of	O
modified	O
biyusan	O
in	O
treating	O
69	O
patients	O
with	O
chronic	O
arsenic	B-NEG
intoxication	I-NEG
.	O

-DOCSTART-	O

These	O
results	O
suggest	O
that	O
Hachimijiogan	O
increases	O
serum	O
estradiol-17	B-NEG
beta	I-NEG
levels	I-NEG
and	O
improves	O
spermatogenesis	B-NEG
in	O
oligozoospermic	O
men	O
.	O

-DOCSTART-	O

Administration	O
of	O
Saireito	O
,	O
a	O
Saiko	O
agent	O
(	O
a	O
Chinese	O
herbal	O
drug	O
)	O
,	O
via	O
a	O
stomach	O
cannula	O
stimulates	O
ACTH	B-NEG
release	O
and	O
proopiomelanocortin	B-NEG
,	O
the	O
precursor	B-NEG
for	I-NEG
ACTH	I-NEG
,	O
gene	B-NEG
expression	I-NEG
in	O
the	O
rat	O
anterior	O
pituitary	O
.	O

-DOCSTART-	O

Chinese	O
medicine	O
Pingandan	O
is	O
an	O
effective	O
anti-MS	B-NEG
drug	O
.	O

-DOCSTART-	O

Resistance	O
of	O
head	B-NEG
louse	I-NEG
(	O
Pediculus	O
humanus	O
capitis	O
de	O
Geer	O
)	O
to	O
DDT	O
in	O
Malaysia	O
.	O

-DOCSTART-	O

The	O
effect	O
of	O
Chinese	O
drug	O
therapy	O
on	O
the	O
patients	O
with	O
male	B-NEG
infertility	I-NEG
.	O

1	O
.	O

Concomitant	O
administration	O
of	O
ninjinto	O
and	O
hachimijiogan	O
on	O
patients	O
with	O
male	O
infertility	O
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
explore	O
the	O
molecular	O
mechanism	O
of	O
inhibiting	O
effects	O
of	O
Reduqing	O
on	O
the	O
release	O
of	O
tumor	B-NEG
necrosis	I-NEG
factor	I-NEG
alpha	I-NEG
(	O
TNF	B-NEG
alpha	I-NEG
)	O
.	O

-DOCSTART-	O

In	O
this	O
study	O
,	O
the	O
effect	O
of	O
Chotosan	O
was	O
studied	O
on	O
nitric	B-NEG
oxide	I-NEG
(	I-NEG
NO	I-NEG
)	I-NEG
function	I-NEG
,	O
hemorheological	B-NEG
factors	I-NEG
and	O
endothelial	B-NEG
function	I-NEG
in	O
stroke-prone	B-NEG
spontaneously	I-NEG
hypertensive	I-NEG
rats	O
(	O
SHR-SP	O
)	O
.	O

-DOCSTART-	O

The	O
concept	O
Sexual	B-NEG
Content-Induced	I-NEG
Delay	I-NEG
(	O
SCID	B-NEG
)	O
refers	O
to	O
a	O
hesitancy	B-NEG
in	O
decision	O
making	O
related	O
to	O
erotic	O
material	O
(	O
Geer	O
Bellard	O
,	O
1996	O
Geer	O
Melton	O
,	O
1997	O
)	O
.	O

-DOCSTART-	O

A	O
deletion	B-NEG
mutant	I-NEG
of	O
pAGO	O
,	O
designated	O
pMH110	O
,	O
has	O
been	O
isolated	O
which	O
removes	O
the	O
normal	O
HSV-1	B-NEG
TK	I-NEG
gene	I-NEG
promoter	I-NEG
but	O
places	O
the	O
promoter	O
of	O
the	O
pBR322	B-NEG
tetracycline-resistance	I-NEG
(	I-NEG
tetr	I-NEG
)	I-NEG
gene	I-NEG
only	O
about	O
400	O
bp	O
from	O
the	O
translational	O
start	O
codon	O
of	O
the	O
HSV-1	B-NEG
TK	I-NEG
polypeptide	I-NEG
.	O

-DOCSTART-	O

The	O
inhibitory	O
effect	O
of	O
Orengedokuto	O
on	O
lipid	B-NEG
peroxide	I-NEG
and	O
sialidase	B-NEG
was	O
investigated	O
using	O
rats	O
affected	O
with	O
carrageenin	O
cotton	O
pellet-induced	O
granuloma	O
and	O
adjuvant	O
arthritis	O
.	O

-DOCSTART-	O

The	O
effects	O
of	O
three	O
Chinese	O
ancient	O
prescriptions	O
,	O
Bazhengsan	O
,	O
Pixiefenqingyin	O
and	O
Wulinsan	O
were	O
determined	O
in	O
vitro	O
against	O
4	O
strains	O
of	O
Diplocous	O
gonorrhoeaes	B-NEG
.	O

-DOCSTART-	O

Protection	O
mechanism	O
of	O
huanshaodan	O
decoction	O
in	O
the	O
brain	B-NEG
.	O

-DOCSTART-	O

Three	O
recombinant	O
plasmids	O
carrying	O
the	O
HSVtk	O
gene	O
driven	O
by	O
the	O
thymidine	O
kinase	O
promoter	O
in	O
single	O
(	O
pAGo	O
)	O
and	O
double	O
copy	O
(	O
pYED	O
)	O
or	O
by	O
the	O
human	O
cytomegalovirus	B-NEG
promoter	O
(	O
pCMVtk	O
)	O
were	O
used	O
for	O
the	O
transfection	O
.	O

-DOCSTART-	O

METHODS	O
Fourty	O
cases	O
with	O
close	O
fractures	B-NEG
of	O
tibia	O
and	O
fibula	O
were	O
included	O
and	O
divided	O
into	O
two	O
groups	O
randomly	O
the	O
experimental	O
group	O
was	O
administrated	O
with	O
phenytoin	O
and	O
Chinese	O
traditional	O
drug-Jiegudan	O
orally	O
,	O
while	O
the	O
control	O
group	O
was	O
given	O
Jiegudan	O
only	O
.	O

-DOCSTART-	O

There	O
was	O
also	O
a	O
significant	O
association	O
between	O
dental	B-NEG
anxiety	I-NEG
and	O
general	O
fearfulness	B-NEG
measured	O
by	O
the	O
Fear	O
Survey	O
Schedule	O
II	O
(	O
Geer	O
,	O
1965	O
)	O
(	O
r	O
0	O
.	O
31	O
p	O
less	O
than	O
0	O
.	O
001	O
)	O
.	O

-DOCSTART-	O

To	O
investigate	O
the	O
protective	O
effects	O
of	O
Wuyaoshunqisan	O
against	O
H2O2-induced	O
apoptosis	B-NEG
in	O
the	O
central	O
nervous	O
system	O
,	O
the	O
3-	O
(	O
4	O
,	O
5-dimethylthiazol-2-yl	O
)	O
-2	O
,	O
5-diphenyltetrazolium	O
bromide	O
(	O
MTT	O
)	O
assay	O
,	O
the	O
terminal	O
deoxynucleotidyl	O
transferase	O
(	O
TdT	O
)	O
-mediated	O
dUTP	O
nick	O
end-labeling	O
(	O
TUNEL	O
)	O
method	O
,	O
flow	O
cytometric	O
analysis	O
,	O
and	O
the	O
DNA	O
fragmentation	O
assay	O
were	O
performed	O
on	O
cells	O
of	O
the	O
hippocampal	O
cell	O
line	O
HiB5	O
.	O

-DOCSTART-	O

After	O
feeding	O
on	O
a	O
viremic	O
mouse	O
,	O
chicken	O
mites	O
,	O
Dermanyssus	O
gallinae	O
(	O
De	O
Geer	O
)	O
,	O
failed	O
to	O
transmit	O
Langat	B-NEG
virus	I-NEG
to	O
naive	O
suckling	O
mice	O
in	O
any	O
trials	O
(	O
0	O
24	O
)	O
.	O

-DOCSTART-	O

Blended	O
effects	O
of	O
herbal	O
components	O
of	O
tokishakuyakusan	O
on	O
somatomedin	B-NEG
C	I-NEG
insulin-like	B-NEG
growth	I-NEG
factor	I-NEG
1	I-NEG
level	O
in	O
rat	O
corpus	O
luteum	O
.	O

-DOCSTART-	O

Saibokuto-pretreated	O
adherent	O
cells	O
failed	O
to	O
present	O
Df	O
antigen	O
to	O
non-adherent	O
responding	O
T	O
cell	O
for	O
induction	O
of	O
their	O
IL2	B-NEG
responsiveness	I-NEG
.	O

-DOCSTART-	O

We	O
have	O
recently	O
found	O
that	O
Tokishakuyakusan	O
(	O
TS	O
)	O
,	O
Keishibukuryogan	O
(	O
KB	O
)	O
or	O
Unkeito	O
(	O
UT	O
)	O
inhibits	O
in	O
vivo	O
DNA	B-NEG
polymerase	I-NEG
alpha	I-NEG
activity	I-NEG
in	O
the	O
rat	O
uterus	O
stimulated	O
by	O
PMS	O
.	O

-DOCSTART-	O

According	O
to	O
the	O
plasmid	O
,	O
the	O
effect	O
of	O
the	O
HSVtk	O
GCV	O
system	O
was	O
confirmed	O
by	O
in	O
vivo	O
experiments	O
and	O
was	O
objectified	O
by	O
a	O
higher	O
tumor	B-NEG
weight	O
reduction	O
with	O
pCMVtk	O
(	O
49	O
)	O
than	O
pAGo	O
(	O
27	O
)	O
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
determine	O
the	O
effects	O
of	O
the	O
takushya	O
portion	O
of	O
choreito	O
,	O
a	O
traditional	O
Chinese	O
treatment	O
for	O
urolithiasis	B-NEG
,	O
on	O
urine	B-NEG
and	O
struvite	B-NEG
crystal	I-NEG
variables	O
in	O
cats	O
fed	O
diets	O
containing	O
takushya	O
.	O

-DOCSTART-	O

These	O
results	O
indicate	O
that	O
the	O
administration	O
of	O
saireito	O
reduces	O
the	O
negative	B-NEG
feedback	I-NEG
effect	I-NEG
of	I-NEG
PSL	I-NEG
on	O
the	O
hypothalamus	O
and	O
pituitary	O
and	O
accelerates	O
the	O
recovery	O
of	O
the	O
hypothalamic	B-NEG
CRH	I-NEG
and	O
pituitary	O
ACTH	B-NEG
level	O
after	O
glucocorticoid	O
treatment	O
.	O

-DOCSTART-	O

However	O
,	O
PPD	O
,	O
OK	O
432	O
,	O
PSK	O
,	O
and	O
Choreito	O
were	O
unable	O
to	O
induce	O
TNF	B-NEG
activity	I-NEG
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
study	O
the	O
anti-aging	O
mechanism	O
of	O
Zuoguiyin	O
(	O
a	O
prescription	O
for	O
tonifying	O
Kindney	O
Yin	O
)	O
and	O
Yishenbao	O
(	O
a	O
prescription	O
for	O
tonifying	O
Kidney	B-NEG
Yang	O
)	O
in	O
presenile	O
mice	O
.	O

-DOCSTART-	O

Effects	O
of	O
hachimijiogan	O
,	O
tokishakuyakusan	O
,	O
keishibukuryogan	O
,	O
ninjinto	O
and	O
unkeito	O
on	O
estrogen	B-NEG
and	O
progesterone	B-NEG
secretion	O
in	O
preovulatory	O
follicles	O
incubated	O
in	O
vitro	O
.	O

-DOCSTART-	O

Sannoshashinto	O
,	O
Shosaikoto	O
and	O
Daisaikoto	O
reduced	O
the	O
hypercholesterolemia	B-NEG
induced	O
by	O
a	O
high	O
cholesterol	O
diet	O
and	O
Sannoshashinto	O
and	O
Daisaikoto	O
improved	O
the	O
atherogenetic	O
index	O
.	O

-DOCSTART-	O

Hypercholesterolemia	O
in	O
rabbits	O
gradually	O
reduced	O
the	O
monocyte	O
number	O
in	O
peripheral	O
blood	O
,	O
whereas	O
Shosaikoto	O
treatment	O
suppressed	O
this	O
decrease	O
in	O
circulating	O
monocytes	B-NEG
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
observe	O
the	O
protective	O
effect	O
of	O
Huanshaodan	O
(	O
HSD	O
)	O
in	O
mouse	O
brain	B-NEG
in	O
a	O
steady	O
ischemia-reperfusion	B-NEG
model	O
.	O

-DOCSTART-	O

Conservative	O
treatment	O
of	O
benign	B-NEG
prostatic	I-NEG
hypertrophy	I-NEG
--clinical	O
effects	O
of	O
increased	O
administration	O
of	O
Hachimijiogan	O
and	O
the	O
relation	O
between	O
these	O
effects	O
and	O
the	O
Sho	O
of	O
Chinese	O
medicine	O
.	O

-DOCSTART-	O

Hochuekkito	O
was	O
administered	O
in	O
2	O
.	O

5	O
g	O
doses	O
three	O
times	O
a	O
day	O
to	O
162	O
patients	O
who	O
complained	O
of	O
anorexia	B-NEG
or	O
lassitude	B-NEG
because	O
of	O
genitourinary	B-NEG
cancer	I-NEG
.	O

-DOCSTART-	O

The	O
mechanism	O
of	O
preventing	O
intrauterine	B-NEG
growth	I-NEG
retardation	I-NEG
with	O
Foshousan	O
plus	O
Danshen	O
by	O
protecting	O
erythrocytes	O
against	O
lipid	O
peroxidation	O
damage	O
was	O
also	O
preliminarily	O
discussed	O
.	O

-DOCSTART-	O

Plasmid	O
pMH1A	O
was	O
derived	O
from	O
pAGO	O
by	O
deletion	O
of	O
2067	O
bp	O
of	O
DNA	O
sequence	O
from	O
pBR322	O
and	O
105	O
bp	O
from	O
the	O
HSV-1	B-NEG
TK	I-NEG
gene	I-NEG
.	O

-DOCSTART-	O

The	O
curative	O
effects	O
of	O
traditional	O
Chinese	O
herbs	O
Dangguishaoyaosan	O
,	O
Chaihujialonggumulitang	O
and	O
two	O
herbs	O
(	O
CHP	O
I	O
and	O
CHP	O
II	O
)	O
developed	O
by	O
the	O
authors	O
on	O
improving	O
the	O
memory	B-NEG
and	O
cognitive	B-NEG
function	I-NEG
of	O
AD	B-NEG
mouse	O
models	O
were	O
studied	O
by	O
the	O
detection	O
of	O
behavioral	O
and	O
histochemical	O
tests	O
,	O
with	O
piracetam	O
serving	O
as	O
control	O
.	O

-DOCSTART-	O

In	O
all	O
groups	O
fed	O
individual	O
components	O
of	O
Wulingsan	O
,	O
the	O
severity	O
of	O
calcinosis	B-NEG
was	O
almost	O
the	O
same	O
as	O
that	O
in	O
the	O
group	O
fed	O
the	O
high	O
phosphorus	O
diet	O
(	O
1	O
.	O
5	O
P	O
)	O
.	O

-DOCSTART-	O

Effects	O
of	O
Tokishakuyakusan	O
,	O
Keishibukuryogan	O
and	O
Unkeito	O
on	O
DNA	B-NEG
polymerase	I-NEG
alpha	I-NEG
activity	I-NEG
in	O
PMS-treated	O
immature	O
rat	O
uterus	O
incubated	O
in	O
vitro	O
.	O

-DOCSTART-	O

This	O
case	O
suggests	O
that	O
methylprednisolone	O
treatment	O
may	O
be	O
insufficient	O
for	O
Shosaikoto-induced	O
pulmonary	B-NEG
edema	I-NEG
,	O
and	O
that	O
mechanical	O
ventilation	O
with	O
PEEP	O
is	O
very	O
effective	O
.	O

-DOCSTART-	O

In	O
this	O
study	O
,	O
using	O
fibroblasts	O
derived	O
from	O
these	O
mouse	O
embryos	O
(	O
Gap-	O
-	O
P	O
.	O
van	O
der	O
Geer	O
et	O
al	O
.	O
,	O
Mol	O
.	O
Cell	O
Biol	O
.	O
,	O
17	O
1840-1847	O
,	O
1997	O
)	O
,	O
we	O
demonstrate	O
that	O
mitogen-activated	B-NEG
protein	I-NEG
kinase	I-NEG
(	O
MAPK	O
)	O
activation	O
is	O
prolonged	O
after	O
epidermal	O
growth	O
factor	O
(	O
EGF	O
)	O
,	O
but	O
not	O
lysophosphatidic	O
acid	O
,	O
stimulation	O
as	O
compared	O
with	O
wild-type	O
cells	O
.	O

-DOCSTART-	O

Ganciclovir-resistant	O
mutant	O
759rD100	O
derived	O
from	O
human	O
cytomegalovirus	B-NEG
strain	O
AD169	O
contains	O
two	O
resistance	O
mutations	O
,	O
one	O
of	O
which	O
is	O
in	O
the	O
UL97	O
gene	O
and	O
results	O
in	O
decreased	O
ganciclovir	O
phosphorylation	O
in	O
infected	O
cells	O
V	O
.	O

Sullivan	O
,	O
C	O
.	O

L	O
.	O

Talarico	O
,	O
S	O
.	O

C	O
.	O

Stanat	O
,	O
M	O
.	O

Davis	O
,	O
D	O
.	O

M	O
.	O

Coen	O
,	O
and	O
K	O
.	O

K	O
.	O

Biron	O
,	O
Nature	O
(	O
London	O
)	O
358	O
162-164	O
,	O
1992	O
.	O

-DOCSTART-	O

Therapeutic	O
strategies	O
comply	O
with	O
SIGO	O
1999	O
guidelines	O
for	O
therapy	O
of	O
CIN	O
and	O
with	O
European	O
guidelines	O
for	O
cervical	O
condylomata	B-NEG
partially	O
.	O

-DOCSTART-	O

Modification	O
of	O
macrophage	O
functions	O
by	O
Shosaikoto	O
(	O
kampo	O
medicine	O
)	O
leads	O
to	O
enhancement	O
of	O
immune	B-NEG
response	I-NEG
.	O

-DOCSTART-	O

CRF	O
antiserum	O
inhibited	O
Saireito-induced	O
plasma	O
ACTH	B-NEG
levels	I-NEG
and	O
proopiomelanocortin	B-NEG
mRNA	I-NEG
levels	I-NEG
in	O
the	O
anterior	O
pituitary	O
.	O

-DOCSTART-	O

METHODS	O
Modified	O
Sanjiasan	O
Granule	O
(	O
MSG	O
)	O
,	O
a	O
representative	O
recipe	O
of	O
NKIR	O
,	O
was	O
used	O
to	O
treat	O
26	O
patients	O
with	O
vascular	B-NEG
dementia	I-NEG
,	O
7	O
g	O
per	O
day	O
orally	O
for	O
one	O
month	O
as	O
one	O
therapeutic	O
course	O
,	O
and	O
the	O
effect	O
of	O
treatment	O
was	O
evaluated	O
by	O
psychic	O
evaluation	O
table	O
.	O

-DOCSTART-	O

Using	O
in	O
vitro	O
autoradiography	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
Kamikihito	O
(	O
KKT	O
)	O
,	O
a	O
traditional	O
Chinese	O
medicine	O
,	O
on	O
the	O
specific	O
binding	O
of	O
3H	O
quinuclidinyl	B-NEG
benzilate	I-NEG
(	O
QNB	O
)	O
and	O
3H	O
N-	O
(	O
1-	O
2-	O
thienyl	B-NEG
cyclohexyl	I-NEG
)	O
-3	O
,	O
4-piperidine	O
(	O
TCP	B-NEG
)	O
in	O
the	O
rat	O
brain	O
.	O

-DOCSTART-	O

Effect	O
of	O
shengmaisan	O
on	O
serum	O
lipid	B-NEG
peroxidation	I-NEG
in	O
acute	O
viral	B-NEG
myocarditis	I-NEG
.	O

-DOCSTART-	O

However	O
,	O
Samultang	O
significantly	O
reduced	O
both	O
cell	B-NEG
death	I-NEG
and	O
NO	B-NEG
production	I-NEG
by	O
LPS	B-NEG
PMA	B-NEG
in	O
a	O
dose-dependent	O
manner	O
.	O

-DOCSTART-	O

These	O
combined	O
data	O
suggests	O
that	O
Saibokuto	O
has	O
a	O
weak	O
immunosuppressive	B-NEG
effect	I-NEG
on	O
Df	O
induced	O
IL2	B-NEG
responsiveness	I-NEG
of	O
lymphocytes	O
from	O
asthmatic	B-NEG
children	O
.	O

-DOCSTART-	O

It	O
was	O
found	O
Chinese	O
medicine	O
Reduqing	O
(	O
RDQ	O
)	O
could	O
inhibit	O
the	O
t	O
ranscription	B-NEG
of	I-NEG
TNF	I-NEG
alpha	I-NEG
mRNA	I-NEG
induced	O
by	O
LPS	O
stimulation	O
(	O
P	O
0	O
.	O
01	O
,	O
compared	O
with	O
the	O
control	O
)	O
.	O

-DOCSTART-	O

Tokishakuyakusan	O
had	O
no	O
adverse	B-NEG
effect	I-NEG
on	O
hormonal	O
levels	O
in	O
either	O
blood	O
or	O
urine	O
.	O

-DOCSTART-	O

In	O
conclusion	O
,	O
goshajinkigan	O
improved	O
ocular	B-NEG
surface	I-NEG
disorders	I-NEG
in	O
patients	O
with	O
insulin-dependent	B-NEG
diabetes	I-NEG
mellitus	I-NEG
.	O

-DOCSTART-	O

CONCLUSIONS	O
It	O
seems	O
that	O
Youguiyin	O
for	O
tonifying	O
Kidney	B-NEG
could	O
increase	O
the	O
reactivity	B-NEG
of	I-NEG
hypothalamic	I-NEG
NE	I-NEG
neuron	I-NEG
,	O
Sijunzi	O
decoction	O
for	O
invigorating	O
Spleen	B-NEG
and	O
Taohong	O
Siwu	O
decoction	O
for	O
promoting	O
blood	B-NEG
circulation	I-NEG
did	O
not	O
show	O
this	O
effect	O
.	O

-DOCSTART-	O

The	O
aging-induced	O
increases	O
of	O
serum	O
total	O
cholesterol	B-NEG
were	O
inhibited	O
by	O
Sannoshashinto	O
and	O
Daisaikoto	O
and	O
the	O
increases	O
of	O
serum	O
triglyceride	O
were	O
reduced	O
by	O
all	O
three	O
kampohozai	O
.	O

-DOCSTART-	O

Having	O
removed	O
a	O
pigeon	O
s	O
nest	O
,	O
a	O
20-year-old	O
woman	O
developed	O
pruritic	O
skin	B-NEG
lesions	I-NEG
due	O
to	O
infestation	O
by	O
the	O
mite	B-NEG
Dermanyssus	O
gallinae	O
(	O
De	O
Geer	O
1778	O
)	O
.	O

-DOCSTART-	O

However	O
,	O
Shosaikoto	O
itself	O
did	O
not	O
induce	O
TAT	B-NEG
activity	I-NEG
in	O
the	O
liver	O
on	O
oral	O
administration	O
or	O
in	O
cultured	O
hepatocytes	O
by	O
direct	O
addition	O
.	O

-DOCSTART-	O

Ten	O
patients	O
(	O
age	O
range	O
,	O
28	O
to	O
36	O
years	O
with	O
a	O
mean	O
of	O
32	O
.	O
3	O
years	O
)	O
with	O
male	B-NEG
infertility	I-NEG
were	O
orally	O
given	O
Ninjinto	O
and	O
Hachimijiogan	O
concomitantly	O
at	O
a	O
daily	O
dose	O
of	O
7	O
.	O

5	O
g	O
each	O
for	O
96	O
to	O
182	O
days	O
(	O
mean	O
116	O
.	O
8	O
days	O
)	O
.	O

-DOCSTART-	O

Effectiveness	O
of	O
a	O
traditional	O
Chinese	O
medicine	O
,	O
Wulingsan	O
,	O
in	O
suppressing	O
the	O
development	O
of	O
nephrocalcinosis	B-NEG
induced	O
by	O
a	O
high	O
phosphorus	O
diet	O
in	O
young	O
rats	O
.	O

-DOCSTART-	O

The	O
nuclear	O
staining	O
of	O
PC12	O
cells	O
clearly	O
showed	O
that	O
Hwansodan	O
attenuated	O
nuclear	O
condensation	B-NEG
and	O
fragmentation	B-NEG
,	O
which	O
represents	O
typical	O
neuronal	O
apoptotic	B-NEG
characteristics	O
.	O

